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ABSTRACT 
MOLECULAR INTERACTIONS BETWEEN THE WilLMS' TUMOR 
TRANSCRIPTION FACTOR AND THE ARYL HYDROCARBON RECEPTOR 
DURING NEPHROGENESIS AND ITS IMPACT ON FETAL PROGRAMMING 
OF RENAL DISEASE 
Adrian Nanez 
December 3, 2007 
Embryonic development requires the orchestration of temporally precise 
genetic events that culminate in the formation of a complete organism. The 
molecular mechanisms responsible for ontogenesis are regulated by 
environmental and somatic factors in utero that activate or repress the 
expression of numerous genetic elements resulting in fetal programming of adult 
diseases. The aryl hydrocarbon receptor (AHR) is an important nuclear 
transcription factor both during embryogenesis and throughout maturity in 
multiple organisms. Building upon interesting studies establishing a direct, novel 
link between AHR anel post-transcriptional regulation of the \Nilms' tumor 
suppressor (WT1) gene, the overall goal of the project was to elucidate the role 
of AHR in the regulation of WT1 during nephrogenesis. The evidence shows that 
v 
in utero exposure to environmentally relevant exposures of benzo(a)pyrene 
(BaP), a polycyclic aromatic hydrocarbon (PAH) and AHR Iligand, results in AHR 
allele-specific deficits in renal development manifested as decreased numbers of 
glomeruli, induction in urinary albumin, and podlocytopenia. These findings were 
consistent with metanephric and organ culture data where PAHs caused AHR 
allele-specific reduction in renal cell differentiation markers, dysregulation of WT1 
mRNA splice variants, and decreases 111 direct 'NT1 transcriptional targets. 
Observed deficits were linked to disruption of constitutive AHR signaling, as 
siRNA-mediated AHR degradation reproduced similar effects. Collectively, this 
evidence defined a novel role for the AHR in renal development and in fetal 
programming of PAH-induced environmental disease. 
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Embryonic development requires the orchestration of temporally precise 
genetic and genetic events that culminate in the formation of a complete 
organism. The molecular mechanisms responsible for ontogenesis are regulated 
by environmental and somatic factors in utero that activate or repress the 
expression of numerous genetic elements. The aryl hydrocarbon receptor (AHR) 
is an important nuclear transcription factor both during embryogenesis and 
throughout maturity in multiple organisms. The discovery of potent, 
environmental chemicals that act as AHR ligands has revealed that dysregulation 
of AHR function during embryonic development can have deleterious effects. Of 
relevance to this project, from a medical perspective, are epidemiological reports 
that maternal exposure to environmental tobacco smoke, a complex mixture of 
chemicals containing high concentrations of ligands of the AHR such as 
polycyclic aromatic hydrocarbons (PAH), mediates developmental abnormalities 
(Sasaki et al., 2006). Also of note is that children of parents who work in 
occupations associated with increased exposure to AHR ligands have a higher 
incidence of Wilms' tumors (Olshan et al., 1990). The discovery of novel 
functions of AHR during development, coupled to molecular interactions of AHR 
with developmental transcription factors highlight a potential mechanism for 
compromised development following disruption of AHR signaling. This 
dissertation focuses on the interactions between AHR and WT1 in the regulation 
of nephrogenesis. 
Renal development proceeds in three morphologically distinguishable 
stages: the pronephros, mesonephros., and metanephros. During 
embryogenesis, the kidney derives from Hle nephric ridge in the intermediate 
mesoderm. At gestational day 8 in mice and day 22 in humans, the pronephric 
duct gives rise to the pronephros which elongates to form the Wolffian duct. A 
morphologically distinct mesonephros appears in mice at gestational day 9.5 and 
day 24 in humans. During mesonephric development, glomeruli are linked to the 
Wolffian duct forming immature nephrons. Shortly thereafter, the mesonephric 
ducts and remnants of the tubular structure are incorporated into development of 
the male genital system and disappear altogether in females (Sakurai and 
Nigam, 2000). 
The metanephros (also referred to as the permanent kidney) develops at 
gestational day 11 in mice and day 28 in humans. During metanephric 
development, the Wolffian duct develops into the ureteric bud which then enters 
the nephrogenic mesenchyme and stimulates condensation of mesenchymal 
cells around the invading ureteric bud. The reciprocal interactions between the 
invading ureteric bud and the metanephric mesenchyme initiate mesenchymal-
epithelial cell transformation (MET) wherein epithelial cells are stimuilated to 
differentiate into the precluding structures for glomerular development (Kuure et 
al.,2000). Both proximal and distal tubules are derived from mesenchymal cells 
receiving differentiation signalls from the invading ureteric bud. Reciprocal 
signals stemming from the induced mesenchyme stimulate branchin~J 
tubulogenesis of the ureteric bud culminating in development of the collecting 
duct system. 
Of importance to our work are the mechanisms that ~Jovern the 
mesenchymal-to-epithelial transformation and the resulting influence on 
metanephric development and renal function. Growth of the ureteric bud from 
the Wolffian duct is regulated by the Wilms' tumor (WT1), Pax2, Lim1, Sall1, and 
Eya1 transcription factors in cooperation with the ancillary proteins formin, Gdnf, 
Ret, and Gfra1 (for review see (Kuure et aI., 20(0). Homozygous deletion of only 
one regulator is sufficient to inhibit ureteric bud outgrowth causing bilateral renal 
agenesis or severe forms of renal dysgenesis (Kreidberg et al., 1993a; Maas et 
al., 1994; Pichel et aI., 1996; Sanchez et al., 1996; Schuchardt et aI., 1994; 
Shawlot and Behringer, 1995a; Torres et al., 1995; Treanor et aI., 1996; Xu et aI, 
1999). Pax2-null mice do not develop the caudal portion of the Wolffian duct and 
do not develop the ureteric bud (Torres et aI, 1995). In WT1-null mice, ureteric 
bud growth is stunted resultin~l in renal aplasia (Kreidberg et al., 1993a). Sall1 
deficiency does not alter ureteric bud growth, but inhibits invasion of the 
metanephric mesenchyme resulting in bilateral renal aplasia (Nishinakamura et 
.., 
j 
aI., 2001). Gdnf produced in the metanephric mesenchyme functions with Ret to 
promote ureteric bud outgrowth. Disruption of either Gdnf or Ret alters renal 
branching morphogenesis dUE~ to improper uretleric bud outlJrowth (Cacalano et 
aI., 1998; Schuchardt et aI., 1!994). 
A cascade of genetic events initiated by transcriptional control from master 
switches including WT1, Lim1, and Pax2 transcription factors regulate MET 
(Figure 1) (Kuure et al., 2000) . WT1 is a known regulator of Pax2 which in turn 
binds to the 5' promoter of Gdnf to induce transcription (Brophy et aI., 2001). 
Lim1-null mice develop a mesonephros, but are devoid of adult kidneys due to 
deficits in Pax2 transcriptional control (Tsang et al., 2000). 'While the importance 
of master switch transcriptional regulators is well-established, the mechanisms 
controlling their function and the downstream consequences are poorly 
understood. 
Other influences in ureteric bud morphogenesis are cellular interactions 
involving extracellular matrices (ECM) from both the ureteric bud and the 
metanephric mesenchyme. ECM protein expression is tightly regulated via 
growth factor signaling pathways which, in turn, are regulated by master switch 
transcription factors. Laminins compose the majority or the mature basement 
membrane (Engel, 1993), and have been shown to participate in branching 
morphogenesis and tubulogenesis. Exposure to anti-laminin5 blocking antibody 
inhibits renal development of cultured metanephroi by preventing association 
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Figure 1. Representation ()f ureteriic bud and metanephric mesenchyme 
interactions in nephron development. Renal cell differentiation requires the 
sequential activation of gene expresslion from several key regulators and 
downstream effectors. These include secreted factors (\/\lnt, FGF, BMP, and 
GDNF), receptors (c-ret), oncogenes, transcription factors (WT1, Pax2, Lim1), 
enzymes (HS2-sulfotransferase), signal transducers (RARa), proteolytic 
enzymes, extracellular matrix (integrin a8), endothelium attractant (VEGF), and 
























with a3~1 and a6~4-integrin receptors (Zent et al., 2001). Laminin 1, consisting of 
a-, ~-, and v-subunits, is a critical component of epithelial cell polarization chiefly 
expressed in comma and S-shaped bodies (Durbeej et aI., '1996; Ekblom, 1993). 
In cultured metanephroi, mesenchymal cell excreted nidogen interacts with the 
laminin1 Y1-subunit to facilitate epithelial cell polarization through a mechanism 
dependent upon dystoglycan and a6~1""integrin (Ekblom et 081., 1994). Exposure 
to antibodies generated against a1, or ()1~1Y1-subunits inhibits development of 
cultured metanephroi either through binding of the dystro~Jlycan membrane 
complex or the ()6~1-integrin receptor (Sonnenberg et 081., 1990). 
Cells stemming from the ureteric bud must digest ECM proteins to 
facilitate invasion. Both matrix metalloproteases (MMPs) and serine proteases 
are known to facilitate renal development. Membrane-type matrix 1 (MT-1-MMP) 
and MMP-2 oligonucleotide antisense inhibits metanephric development 
dependent on the TIMP-2 inhibitor activity (Kanwar et 081., 1999; Ota et 081 .. 1998). 
While t-PA and u-PA serine proteases are expressed in developing metanephroi, 
and have been shown to participate in tubulogenesis in organ culture, mouse 
models deficient in expression of either protein have a normal renal phenotype 
(Carmeliet et al., 1994). Thus, renal morphogenesis requires the function of 
master switch transcription factors which directly or indirectly regulate 
intra/extracellular signaling that facilitate renal cell differentiation, branching 
morphogenesis, and ultimately nephro~Jenesis. 
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The Wilms' tumor suppressor transcription factor (VVT1), in concert with a 
variety of transcriptional co-regulators, guides renal development through both 
direct and indirect modulation of target genes necessary for renal cell 
differentiation including syndecan1 (Synd1), Pax2, E-cadherin (E-cad), insulin-like 
growth factor /I (lgf2r), epidermal growth factor receptor (E!~fr) and retinoic acid 
receptor-a (Rara) (Hosono et aI., 2000; Hosono et aI., 19199; Ryan et aI., 1995). 
The WT1 gene encodes a Cisr His2 zinc fingered protein that can regulate 
biological events via transcriptional activation of target genes or by association 
with factors participating in RNA processing. The WT1 gene was first 
characterized as one of the gE~netic causes of the pediatric nephroblastoma, 
Wilms' tumor, which is histolo!Jically characterized by cellular populations of 
epithelial, stromal, and undifferentiated phenotype (Bennin!Jton and Beckwith, 
1975). Whille WT1 is only inactivated in 15% of Wilms' tumors, dysregulation of 
WT1 function results in clinical manifestation of developmental deficiencies 
affecting genitourinary development such as WAGR (Wilms' tumor, aniridia, 
genitourinary defects and mental retardation), Beckwith-\/viedemann, Denys-
Drash, and Frasier syndrome (for review see(Lee and HabE~r. 2001 )). 
Of importance to our work is the ability of WT1 to function as a "master 
switch" regulating mesenchymal-epithelial differentiation in renal development 
(Avner, 1993). In both humans and mice, WT1 protein is expressed in the 
condensing mesenchyme, renal vesicle, and glomerular epithelium of developing 
kidney (Buckler et al., 1991; Pritchard-Jones et al., 1990). In adulthood, visceral 
8 
epithelial cells (podocytes) of the kidnE!y and Sertoli cells of the seminiferous 
tubules in the testis are the only populations that express \/\/T1. Homozygous 
WT1-/- mice do not develop normally, die in utero, and do not differentiate into 
metanephric kidney from the existing pronephros (Kreidber~l et al. ,1993b). 
WT1 activity is regulated in cis by different ratios of its own splice variants 
or in trans by proteins such as bone marrow zinc finger 2 (BMZF2), Pax2, and 
Par4 (Hohenstein and Hastie, 2006; Lee et aI., 2002). Wr'l protein expression 
varies from 36 possible isoforrns resulting from alternative splicing, start codons, 
and RNA editing (Filgure 2) (Hohenstein and Hastie, 2006). Perhaps the most 
studied regulatory mechanism involves the formation of \/\/T'l ±KTS splice 
variants. KTS splice variants are formed at a site in exon 9 via the insertion of a 
Iysine-threonine-serine (KTS) between the third and fourt~l zinc finger. The 
resulting change tarlgets -KTS WT1 protein expression for the nucleus and 
modifies DNA binding specificity leading to activation and/or repression of 
different genetic elements (Menke et aI., 1998b; Niksic et al., 2004). WT1 protein 
from the +KTS mRNA transcript localizes to the nucleus and is thou!~ht to 
participate in RNA processing via interactions with known splicing factors such as 
U2AF65 (Davies et aI., 1998; Ladomery et aI., 2003; Larsson et aI., 1995). In 
mouse models, deletion of either the -KTS or the +KTS is lethal soon after birth 
due to distinct renal deficits (Hammes et aI., 2001). In humans, reduced 
WT1 +KTS mRNA isoform results in severE~ kidney and gonad developmental 
deficits, collE~ctively known as Frasier syndrome (Barbaux et al., 1997). Similarly, 
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Figure 2. Schematic representation of the WT1 gene. Accounting for 
alternative transcriptional start sites and rnRNA splicing, the WT1 locus encodes 
for at least a theoretical maximum of 36 isoforms. Alternative start codons, 
exons, splice sites, and RNA editing are depicted in red. Functional domains of 
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mouse models with homozygous deletion of the -KTS WT1 variant results in 
small kidneys, reduced glomeruli number, a decrease in nephrogenic area, as 
well as streak gonads (Hammes et al., 2001). +KTS-null mice achieve a higher 
degree of renal maturation, compared to --KTS -/- mice, characterized by 
immature glomeruli and undifferentiated podocyte cell populations resulting in 
renal nephropathy E~videnced by hematuria (Hammes et al., 2001). This 
demonstrates that the integrity of WT1 function as regulated by mRNA splice 
variant ratio is critical to renal development. 
Addition of 1"7 amino acids comprising the entirety of exon 5 (±17aa) 
occurs in a region chiefly thought to re!~ulate transactivation with regulatory 
partners and nuclear translocation (Robelis, 2005; Wang et a/., 1995). Insertion 
or deletion of 17aa does not alter renal development morphologically, and to date 
the impact of these isoforms on WT1 function remains uncertain. 
Overexpression of +17aa has been reported in human Wilms' tumor (Simms et 
al., 1995). In cell culture models, +17aa overexpression alters cellular 
morphology and induces proliferation (Hewitt and Saunders, 1996). In lymphoma 
cell lines +17aa oVE~rexpression inhibits apoptosis by repressing expression the 
pro-apoptotic protein Bak (Ito et a/., 2006). Our work shows that induction of 
+17aa WT1 protein correlates with loss of renal cell differentiation markers Igf1 r, 
Wnt4 and E-cad (Falahatpisheh and Ramos, 2007). 
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Yet another regulatory domain occurs at the N-terminal residues 1-182 
which encode a dimerization region implicated in the regulatory mechanism 
exerted by dominant negative mutants (Englert et a/., 1995; Reddy et aI., 1995). 
To date, the mechanisms regulating WT1 function are poorly understood. The 
majority of evidence supports the theory that WT1 is regulated by relative 
abundance of mRNA isoforms resulting in proteins that function to either repress 
or promote transcription of genetic targets necessary for renal cell differentiation. 
The relative contribution that +KTS plays in RNA processing has yet to be 
determined .. The molecular mechanisms re!~ulating WT1 transcription, splicing, 
and overall function remain uncertain. Work in our laboratory suggests that 
integrity of AHR signaling functions directly and/or indirectly in regulation of WT1 
mRNA ratios. 
The aryl hydrocarbon receptor was the first characterized member of the basic 
helix loop helix- Per Arnt Sim (bHLH-PAS) family of transcription factors (Figure 
3). The PAS domain is characterized by a region of homology between the 
founding members Per (the protein product of the Orosophila Period gene) 
(Reddy et al., 1986), ARNT (the AHR nuclear translocator) (Hoffman et aI., 
1991), and Sim (the product of the Orosophila-Single minded locus) (Nambu et 
al., 1991). Eukaryotic PAS domains serve as recognition sites for interactions 
with other PAS proteins, cellular chaperones, or in the case of the AHR, a 
regulatory ligand binding site. The bHLH domain also participates in recognition 
of other bHLH and facilitates recognition of the major groove of tar~let genetic 
13 
Figure 3. Members of the PAS family. Domain structures for the founding 
members PER, ARNT, and SIM are shown as well as others including AHR, HIF-
1, TRH, and SIMILAR The basic region is depicted in blue, basic helix-Ioop-












elements (Murre et a/., 1994). While bHLH-PAS proteins share similar structure 
and function, the AHR is the only member known to be re!~ulated by ligand 
activation (Figure 4). 
The AHR was initially characterized due to its participation in the induction 
of xenobiotic metabolizing enzymes (XMEs) necessary for removal of exo!~enous 
compounds. Early work showed that response to xenobiotics such as polycyclic 
aromatic hydrocarbons (PAHs), known inducers of XMEs, varied between strains 
of mice that were highly responsive (C57BLl6,J) and nonresponsive (DBA/2) with 
respect to induction of XME machinery. Genetic manipulation creating congenic 
strains expressing different AHR alleles identified a single autosomal locus 
coined AH locus (Goujon et a/., 1972; Nebert et a/., 1972). However, it was not 
until the development of high-affinity radioligands, AHR-specific anti:bodies, and 
purified receptor fractions that AHR-ligand interactions were deduced. 
A. combination of various techniques has led to our current understanding 
of AHR biology in which ligand binding results in AHR disassociation from two 
molecules of the chaperone heat shock protein 90 (HSP90), binds the X-
associated protein 2 (XAP2) and p32 (Figure 5). The resulting complex exposes 
a nuclear localization sequence that facilitates nuclear translocation. This 
complex, in turn, binds to the aryl hydrocarbon receptor nuclear translocator 
(ARNT) resulting in DNA binding to sequences containing 5'-GCGGGGGCG-3' 
and (TCC)n repeats (Denison and Nagy, 2003). Translocation of thE~ AHR·ligand 
16 
Figure 4. Molecular structure of the AHR. The nuclear localization (NLS), 
bHLH, PAS, and transactivation (TAD) domains are labeled. Areas 
characterized for dimerization, ligand binding, and repressor bindinn are labeled 
and depicted with lines. Cys 216 has been highlighted as a key residue for DNA 
binding and Ala 374 for high affinity ligand binding. 
17 
Figure 4 




Figure S. The molecular mechanism of AHR-regulated gene expression as 
mediatE~d by ligand activation. Ligand binding results in AHR disassociation 
from two molecules of the chaperone heat shock protein 90 (HSP90), binds the 
X-associated protein 2 (XAP2) and p32. The resulting complex exposes a 
nuclear localization sequence that facilitates nuclear translocation. This complex 
in turn binds to the aryl hydrocarbon receptor nuclear translocator (ARNT) 
resultin~1 in DNA binding to AHR response element (AHRRE) sequences 
containing 5'-GCGGGGGCG-3' and (TCC)n repeats. Translocation of the Ahr-
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complex to the nucleus can also trigger proteolytic degradation regardless of 
ARNT binding (Roberts and Whitelaw, 1999). AHR is also regulated by negative 
feedback inhibition in which the nuclear AHR complex activates transcription of 
the AHR repressor protein (AHRR) responsible for binding the xenobiotic 
response element (XRE) (Mimura et aI., 1999). 
The induction of XMEs resulting from AHR-ligand binding is the most 
widely studied function of AHR. AHR interacts with xenobiotic response 
elements (XREs) in the regulatory regions of genes such as cytochrome P450 1A 
(CYP1A 1), CYP1A2, CYP1 B1, glutathione-S-transferase Ya (GSTYa) and 
UGT1A6 NAD(P)H-quinone oxidoreductase which, in turn, function to metabolize 
PAHs into compounds modified for excretion via glutathione conjugation. An 
example relevant to our work involves the biotransformation of benzo(a)pyrene 
(BaP), a common environmental pollutant that among other effects acts as an 
AHR ligand (Figure 6). Upon exposure to BaP, P450 exprE~ssion is induced to 
catalyze the epoxidation of the parent hydrocarbon into BaP 7,8 epoxide and 
then into BaP 7,8 diol-9, 1 0 epoxide (Parkinson, 2001). While these metabolic 
steps are necessary for clearance of the hydrocarbon, they also activate BaP into 
compounds that exert deleterious effects ranging from DNA mutagenesis, 
oxidative stress, protein modifications, and disruption of molecular signaling 
pathways (for review see (Miller and Ramos, 2001 a). 
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Figure 6. Metabolic activation of BaP. BaP is metabolized into BaP 7,8 
epoxide by cytochrome P450's. Hydrolysis mediated by epoxide hydrolase (EH) 
creates BaP 7,8 diol which is further metabolized by cytochrome P450's into the 













AHR ligands are categorized as either synthetic in nature (resulting from a 
nonbiological process such as combustion or de novo synthesis) (Figure 7) or as 
naturally occurring (synthesized as part of a biological process) (Figure 8). 
Further classification into exogenous and or endogenous is difficult due to dietary 
ligands that are technically exogenous in nature, but that are transformed into 
ligands by natural biological processes. The high affinity ligands such as 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCOO), BaP and 3-methylcolanthrene (3MC) are 
synthetic in nature. Synthetic ligands bind AHR with high affinities in the pM to 
nM range whereas naturally occurring ligands such as the tryptophan metabolites 
bind with lower affinities in the nM to iJM range. 
Historically, studies have focused on the ubiquitous high affinity ligands 
and the resulting regulation of AHR biology, however evolutionary comparison 
has shown that the AHR gene is conserved across both vertebrate and 
invertebrate species of which many are not exposed to classical aromatic ligands 
(Hahn, 2002; Hahn et al., 2006). This poses the question: Are there true 
endogenous ligands that regulate AHR activity? 
The first report of a candidate endogenous AHR ligand came from studies 
in which Hepa1c1c7 cells were exposed to hemin, bilirubin and biliverdin. 
Bilirubin induced CYP1A 1 mRNA and 7-ethoxyresorufin-O-deethylase (EROO) 
activity in a dose-dependent manner (Sinal and Bend, 1997). In agreement with 
24 
Figure 7. Structures of selected classical AHR ligands that are considered 
synthetic in nature. All are known inducers of AHR-dependent gene expression 
(Denison and Nagy, 2003). 
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Figure 7 
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Figure 8. Structures of AHR ligands categorized as naturally occurring. All 
are derivatives arising from metabolism of tryptophan by mammalian enzymes 
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studies identifying tryptophan metabolites as AHR ligand, aspartate 
aminotransferase expressed in mouse heart tissue activated AHR signaling by 
converting L-tryptophan into indole-3-pyruvate (Bittinger et aI., 2003). The 
compound 2-(1'H-indole-3'-carbonyl)-thiaxole-4-carboxylic acid methyl ester (ITE) 
was isolated from mouse tissue and found to act as a potent AHR agonist in cell 
extracts, cultured cells, and in vivo animal models as evidenced by AHR binding, 
CYP1A 1 protein induction and xenobiotic response element (XRE) reporter 
activity (Henry et al., 2006). While investigating the role of AHR in shear stress 
and vascular physiology, low density lipoprotein (LDL) was found to increase 
AHR signaling due largely to lipoprotein modification (McMillan and Bradfield, 
2007a). The relative contribution of either of these ligands to AHR function in 
vivo remains to be elucidated. However, it is likely that AHR signaling in vivo is 
regulated by endogenous ligands. 
Genetic polymorph isms in murine strains aided the discovery and 
characterization of the AHR gene. In mice, four distinct AHR alleles, AHb-1 , AHb-
2, AHb-3, and Af-f have been characterized (Poland etal., 1994). C57BLl6J mice 
express AHb-1 which encodes for the amino acid alanine at codon 375 resulting in 
a 10-fold higher ligand binding affinity (Kd=6-1 OpM) compared to DBA/2 mice 
(Kd=37pM) that express the Af-f allele containing valine at codon 375 (Okey et 
aI., 1989). Accordingly, the congenic strain D2NAhrd was developed and 
contains the exact genetic background as the C57BLl6J strain except for 
expression of the AHRd allele. While polymorphisms in mouse AHR typically 
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occur in the ligand binding domain, human polymorph isms manifest in the 
transactivation domain at codons 517,554, and 570 (Harper et al., 2002). As in 
mice, human populations express AHR variants that can vary 10-fold in TCDD 
binding affinity. However, the mechanisms for this occurrence do not involve the 
517, 554, and 570 codon polymorphic variants (Harper et aI., 2002; Nebert et aI., 
2004). The combination of 517 and 554 polymorphisms results in AHR protein 
that binds TCDD and DNA, but does not sustain CYP1A1 induction (Wong et al., 
2001a; Wong et al., 2001b). It is thought that expression of the lower affinity 
AHR, similar to the protein product from the murine AHRd allele, protects the 
majority of the human population from the toxic effects of PAHs (Harper et aJ., 
2002). With the abundance of environmental agents able to activate AHR, it is 
crucial to determine the exact nature of human AHR allelic variation and the 
resulting consequences on AHR function. 
The bulk of AHR studies have focused on modulation and/or participation 
in the response to and clearance of xenobiotic compounds. Evidence continues 
to mount implicating AHR in proliferation, development, adhesion and migration, 
and proteasomal degradation of steroid hormone receptors (for reviews see 
(8arouki et al., 2007; Ohtake et al., 2007)). Studies using AHR -/- mice support a 
scenario in which the AHR acts as an important nuclear transcription factor 
during embryogenesis and throughout maturity in multiple organisms. AHR-/-
mice exhibit deficits in vascular structures stemming from a failure of the ductus 
venosus to close and result in reduced liver weight, microvesicular fatty 
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metamorphosis, prolonged extramedullary hematopoeisis, and portal 
hypercellularity (Fernandez-Salguero et aI., 1995; Lahvis et aI., 2000; Lahvis et 
al., 2005; Schmidt et aI., 1996). Our lab has shown that AHR-null mice exhibit 
delayed nephrogenesis resulting in compromised renal development as 
evidenced by nephropenia and decreases in renal vasculature (Falahatpisheh 
and Ramos, 2003; McMillan and Bradfield, 2007b). We have also shown that 
these changes can be reproduced by downregulation of AHR protein upon ligand 
binding. 
Of direct relevance to studies of renal function are experiments in which 
AHR -/- mice were found to have cardiac hypertrophy and elevated mean arterial 
pressure (Lund et aI., 2003; Lund et al., 2006). Hypertension correlated to 
increased in endothelin-1 and angiotensin II, k.nown regulators of cardiomyocyte 
hypertrophy (Gavras and Gavras, 2002; Yamazaki et aI., 1996). Angiotensin \I is 
a potent renal vasoconstrictor that constricts efferent arterioles and increases 
blood pressure. Thus, it is possible that hypertension in AHR -/- mice is caused 
by compromised renal development; although this hypothesis remains to be 
tested. More studies are required to determine how environmental PAH 
exposure affects AHR protein expression and function in the context of 
organogenesis. 
As noted previously, PAHs are compounds formed during the incomplete 
burning of organic substances such as gas, oil, wood, tobacco, and charbroiled 
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meat. The primary source of exposure occurs through inhalation of compounds 
via tobacco smoke, wood smoke, ambient air, and dietary intake. PAHs like BaP 
are hlighly lipophilic chemicals that move across cell membranes with relative 
ease. Upon entry into the cells they associate with hydrophobic molecules and 
are dispersed throughout the cell accumulating in the mitochondria and nucleus 
(Barhoumi et al., 2000; Zhu et al., 1995). Once in the bloodstream they bind 
albumin and lipoproteins and are rapidly distributed throughout the body (for 
review see (Miller and Ramos, 2001 b)). Average PAH exposure can range from 
3 to 15 jJg/day depending on dietary intake. Humans exposed to active or 
passive smoke can receive as much as 30 jJg/day (Menzie et al., 1992a; Menzie 
etal., 1992b; Santodonato etal., 1981). 
In mouse models of inhalation exposure, BaP bioaccumulates primarily in 
the kidney and to a lesser extent in the liver (Mitchell, 1982). Consistent with the 
known expression of XMEs, elimination in the liver occurs at 12 hours post-
exposure while Significant amounts of BaP are still present in the kidneys for up 
to 48 hours (Mitchell, 1982). In utero exposure with radiolabeled BaP show that 
BaP enters the fetus and activates classical responses triggered by PAH 
metabolism including increases in CYP450 and BaP hydroxylase expression 
(Neubert and Tapken, 1988a; Neubert and Tapken, 1988b). 
PAH exposure is known to be a causative factor in carcinogenesis, 
atherogenesis, and embryotoxicity (for review see (Miller and Ramos, 2001 b)). 
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In mice, metabolism of BaP into compounds that give rise to DNA adduct 
formation results in tumor formation in both skin and systemic models. 
Intraperitoneal injections of the 7,8-diol-9, 10-epoxide (BPDE) metabolite induces 
systemic malignant lymphoma as a result of DNA mutagenesis (Kapitulnik et aI., 
1977). PAHs affect growth and differentiation of aortic smooth muscle cells and 
may participate in atherogenesis (Holderman et al., 2000; Kerzee and Ramos, 
2000; Ramos and Parrish, 1995). The mechanistic causalities of PAH-induced 
diseases are complicated by the variety of effects they exert such as DNA 
mutagenesis, oxidative stress, protein oxidation, and modifications of signal 
transduction pathways. 
PAH exposure during critical windows of fetal development exhibit 
teratogenic and embryotoxic effects (Lummus and Henningsen, 1995; 
MacKenzie and Angevine, 1981a; Rodriquez et al., 1999; Wells et al., 1997; 
Winn and Wells, 1997). Murine in utero exposure of 150 mg/kg BaP causes T 
cell deficiencies in offspring (Lummus and Henningsen, 1995). In utero exposure 
to as little as 10 IJg/kg results in reproductive deficits in both male and female 
offspring manifest by a reduction in the size of seminiferous tubules and corpus 
lutea deficiencies, respectively (Mackenzie and Angevine, 1981 b). 
Of relevance to our work is the extensive evidence linking maternal PAH 
exposure to fetal deficits. Fetal tobacco syndrome is characterized by maternal 
exposure to PAHs in the form of tobacco smoke and results in reductions in birth 
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weight, height, thoracic circumference (for review see (Nieburg et al., 1985)). 
Evidence supports the theory that active smoking morphologically alters the 
placenta compromising fetal capillary function resulting in a reduction of oxygen 
flow to the developing fetus (Bush et al., 2000a; Bush et al., 2000b). Sasaki et 
al. has provided the first in vivo human evidence that AHR, CYP1A 1, and GST1 
genetic polymorph isms influence fe~tal health upon maternal tobacco smoke 
exposure. Expression of AHR protein with arg/arg at codon 211 significantly 
lowered birth weight and length. Interestingly, variants of enzymes regulated by 
AHR activity (CYP1A1 m1/m2 + m2/m2) or involved in PAH elimination (GSTM1-
/-) sensitized fetuses to the effects of maternal smoking (Sasaki et a/., 2006). 
This study directly links PAH exposure to deficits in AHR signaling in the context 
of fetal programming. 
Fetal programming is a process whereby a stimulus at a sensitive critical 
period of development induces lasting effects on the structure or function of the 
organism (Barker, 2004). Some of the strongest evidence of fetal programming 
involves the correlation betwe~~n low birth weight (LBW) and compromised renal 
development. Chronic kidney disease (CKO) affects greater than 20 million 
people in the U.S .. It is thought that the two major causes are hypertension 
(HTN) and diabetes mellitus. The kidney is a key regulator of HTN. Most genetic 
mutations associated with HTI'J involve proteins expressed in the kidney and 
regulated renal function such as epithelial Na+ channel (Lifton et al., 2001). This 
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led Brenner et al. to postulate tlhat HTN may be associated with congenital 
deficits in nephron number resultin~l in impaired renal function. 
In humans, a direct com31ation exists between birth weight and nephron 
number. LBW humans have been shown to have reduced nephron numbers and 
glomerular hypertrophy. An increase in 1 kg of birth weight results in the addition 
of 250,000 nephrons (Hoy et al., 2003; Hughson et al., 2003). LBW adults with 
low nephron number are prone to nnicroalbuminuria, proteinuria, and decreased 
glomerular filtration (Celsi et al., 1998; Nwagwu et al., 2000; Sanders et al., 
2005). Thus, it is likely that intrauterine factors, including PAHs, compromise 
renal development resulting in low nephron number. The reduced renal capacity 
may result in glomerular hypertension and subsequent compensatory 
hypertrophy that in turn leads to disruption of the glomerular basement 
membrane manifest as glomerulosclerosis. Continued glomerular injury may 
lead to increases in nephron loss further reducing renal capacity as evidenced by 
decreases in Na+ excretion and glomerular filtration rates. As depicted in Figure 
9, this culminates in HTN exacerbating glomerulosclerosis, nephron loss, and 
proceeds until progressive renal failure. 
The work completed as part of this dissertation builds upon interesting 
studies completed in the Ramos laboratory for the past 10 years establishing a 
direct link between AHR and cieficits in renal cell differentiation (Alejandro et al., 
2000) and post-transcriptional regulation of WT1 isoform expression 
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Figure 9. Proposed mechanism IOf fetall programming in hypertension, 
renal disease, and glomerulalr filtration. Intrauterine factors, including PAHs, 
compromise renal development resulting in low nephron number (Celsi et a/., 
1998; Nwagwu et al., 2000; Sanders et al., 2005). Reduced renal capacity 
results in glomerular hypertension and subsequent compensatory hypertrophy 
that in turn leads to disruption of thl3 glomerular basement membrane manifested 
as glomerulosclerosis. Continued !~Iomerular injury leads to increases in 
nephron loss further reducing renal capacity as evidenced by decreases in Na+ 
excretion and glomerular filtration rates. This culminates in HTN exacerbating 
glomerulosclerosis, nephron loss, and proceeds until progressive renal failure 
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(Falahatpisheh and Ramos, 2003). Using a metanephric kidney organ culture 
system, we have shown that exposure to BaP, a hydrocarbon ligand for the AHR, 
inhibits nephrogenesis and increases -KTS/+KTS WT1 mRNA ratios. 
Hydrocarbon challenge of metanephroi extracted from AHR knockout mice are 
protected from BaP-induced deficits in nephrogenesis and express higher 
amounts of +KTS mRNA, indicating that AHR is required in nephrogenesis. 
The overall goal of the research summarized in this dissertation was to 
elucidate the role of AHR in the regulation of WT1 function during nephrogenesis. 
Specifically, studies were conducted to test the hypothesis that ligand-activated 
AHR regulates murine nephrogenesis in vivo by altering expression of renal cell 
differentiation genes through modulation of WT1 mRNA splicing. This hypothesis 
was tested by three specific aims deSigned to: 
1) Determine whether in utero BaP exposure causes AHR dependent 
inhibition of nephrogenesis and alterations in WT1 mRNA splicing; 
2) Elucidate the time-related effects of AHR ligands on nephrogenesis 
and WT1 splicing, and; 
3) Evaluate the influence of alterations in WT1 splicing on downstream 
WT1 targets and cell differentiation. 
In chapter 2, we evaluate the impact of in utero BaP exposure on 
nephrogenesis and WT1 mRNA splicing. Previous work has established that 
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exposure of metanephric kidney cultures (isolated from C57BLl6J wild type mice) 
for 4 days to BaP results in inhibition of nephrogenesis and modulation of WT1 
mRNA variants. AHR-null metanephroi exhibit similar deficits in nephrogenesis 
in the absence of BaP exposure (Falahatpisheh and Ramos, 2003). While this 
regimen was adequate for initial studies, httle was known about the effects of in 
utero BaP exposure on nephrogenesis and WT1 mRNA splicing in vivo. Thus, 
studies were designed to evaluate the impact of BaP treatment on pregnant 
C57BLl6J and D2NAHRd mice expressin~1 the responsive and nonresponsive 
AHR alleles, respectively. Of particular relevance was the fact that our studies 
examined concentrations of BaP known to be relevant to human exposures to 
the hydrocarbon. We hypothesized that iln utero BaP exposure results in AHR 
mediated inhibition of renal development and alterations in WT1 mRNA splicing. 
Chapter 3 summarizes the results of studies completed to define the 
kinetic profiles of BaP-induced inhibition of nephrogenesis and alteration of WT1 
splicing. Experiments focused on definin!J the mechanism for AHR participation 
in renal developmental control. Previous work established that exposure of 
metanephric kidney cultures to BaP for 4 days results in inhibition of nephrogenic 
differentiation and modulation of WT1 isoforms regulated by AHR. While this 
work implicated a relationship between AHR and WT1, the kinetic profiles of AHR 
activation, changes in WT1 mRNA splicing, and inhibition of nephrogenic 
inhibition had not been defined. Thus, experiments were conducted to determine 
the extent to which sub-chronic BaP exposure induces nephrogenic inhibition 
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and alterations in AHR-WT1 signaling. Through the use of pharmacological AHR 
antagonists and D2NAHRd metanephroi we examined the molecular mechanism 
by which PAHs affect nephrogenesis. We hypothesized that BaP-induced 
disruption of AHR signaling downregulates renal cell differentiation through a 
pathway that involves altered conservation of WT1 mRNA splice variant ratios. 
Chapter 4 focuses on the influence of alterations in WT1 splicing on 
downstream WT1 targets and cell differentiation. The key event in 
nephrogenesis is the transdifferentiation of mesenchymal cells to epithelial cells. 
Recent work has shown that degradation of AHR via ligand-activated 
ubiquitination or siRNA interference induces the +17aa and -KTS splice variants 
of the Wt1 gene (Falahatpisheh and Ramos, 2003; Falahatpisheh and Ramos, 
2005). Different WT1 isoforms are believed to promote and/or repress different 
genetic targets (Hosono et al., 1999; Reddy and Licht, 1996), suggesting that 
epithelial conversion is differentially influenced by different WT1 spllice variants. 
The concept that different WT1 splice varilants regulate different functions is 
consistent with the notion that translation of -KTS mRNA produces a protein 
product that localizes to the nucleus, whereas the +KTS protein displays 
preferential cytoplasmic localization. Murine kidney cell lines at two different 
stages of cellular differentiation were used to determine the role of alterations in 
WT1 splicing in the regulation of renal cell differentiation. Subsequent 
experiments were conducted to determine if alterations in various VVT1 isoforms 
lead to induction/repression of proteins directly regulated by WT1 and involved in 
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metanephric development. We hypothesized that overexpression of -KTS or the 
+17aa WT1 isoforms compromises differentiation of mK4, but not mK3 cell lines 
and selectively modulate downstream tar£lets of WT1. 
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CHAPTER 2 
DEREGULATION OF FETAL PROGRAMMING IN THE DEVELOPING KIDNEY 
BY I3ENZO(A)PYRENE 
Summary 
Polycyclic aromatic hydrocarbons (PAHs) are environmentally ubiquitous 
chemicals identified as potential disruptors of developmental programming and 
inducers of transformed phenotypes in several organ systems. Recent studies in 
this laboratory have established that exposure of developing kidneys in vitro to 
SaP, a prototypical PAH, causes deficits in renal cell differentiation and ablates 
nephrogenesis. The present studies were conducted to determine if similar 
changes are seen in vivo following in utero exposure to BaP at concentrations 
relevant to those likely to be encountered by humans during environmental 
exposures. Pregnant C57BLl6J (C57) and B6.02N-Ah,o/J (02N) mice 
expressing the wild type AHR allele or an AHR allele with reduced ligand binding 
affinity, respectively, were treated by gavage with 0.1 or 0.5 mg/kg BaP daily 
beginning 10 days post coitum (dpc) through 13. This exposure regimen was 
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designed to mimic human exposure levels during periods of nephrogenesis. 
Pregnant mice were allowed to come to term and offspring were examined at 7 
days and at 12 months post partum for indicators of renal morphology and 
measurements of renal function. Exposure to 0.1 mg/kg and 0.5 mg/kg BaP 
caused AHR allele-specific decrE~ases in ~llomerular number and altered renal 
morphology compared to vehicle-treated controls. Developmental deficits were 
primarily of glomerular origin, as evidenced by decreased podocyte numbers and 
increased levels of urinary albumin, a marker of glomerular function. Markers for 
collecting duct and distal tubule injury, namely, rat papillary antigen 1 (RPA 1) and 
glutathione S-transferase Yb1 (GSTYb1), were unchanged. Both morphological 
and molecular endpoints correlated with the loss of the AHR protein in kidneys 
from BaP-exposed mice. These results implicate BaP as an influential factor in 
fetal programming during the course of murine renal development. 
Introduction 
Fetal programming is a process whereby a stimulus at a sensitive critical 
window of development induces lasting effects on the structure or function of the 
organism (Barker, 2004). Correlations between low birth weight (LBW) and renal 
development have provided some of the strongest evidence for environmental 
disruption of fetal programming. LBW humans have reduced nephron numbers 
and glomerular hypertrophy. In humans, an increase of 1 kg in birth weight 
results in the addition of 250,0010 nephrons (Hoy et aI., 2003; Hughson et al., 
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2003). LBW adults with low nephron number are prone to microalbuminuria, 
proteinuria, and decreased glomerular filtration (Celsi et al., 1998; Nwagwu et aJ., 
2000; Sanders et aI.., 2005). Reduced renal capacity results in glomerular 
hypertension and subsequent compensatory hypertrophy that in turn leads to 
disruption of the glomerular basement membrane manifested as 
glomerulosclerosis. Sustained glomerular injury exacerbates nephron loss 
further reducing renal glomerular filtration rate. A reduction in renal capacity 
further increases blood pressure and completes a futile cycle of 
glomerulosclerosis and nephron loss that may ultimately result in progressive 
renal failure (Zandi-Nejad et al., 2006). Thus, it is important to examine the 
mechanisms by which intrauterine factors disrupt ontogenesis. 
PAHs are compounds formed during the incomplete burning of organic 
substances such as gas, oil, wood, tobacco, and charbroiled meat. Routes of 
exposure include inhalation via tobacco smoke, wood smoke, ambient air, as well 
as dietary intake (USDHHS, 1995). PAH exposure is a known causative factor in 
carcinogenesis, atherogenesis, and embryotoxicity and these effects are 
believed to be mediated by mechanisms involving DNA mutagenesis, oxidative 
stress, protein oxidation, and deficits in signal transduction (for review see (Miller 
and Ramos, 2001 b)). PAHs acting as ligands of nuclear transcription factors 
such as aryl hydrocarbon receptor (AHR) can induce deficits in embryogenesis 
via disruption of constitutive AHR signaling (Falahatpisheh and Ramos, 2003; 
Nanez and Ramos, 2007; Peters et al., 11999a). 
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AHR is a basic helix-loop-helix transcription factor activated by 
endogenous and exogenous ligands including PAHs. Upon ligand binding, AHR 
disassociates from two molecules of the chaperone heat shock protein 90 
(HSP90), binds the X-associated protein 2. (XAP2) and p32. The resulting 
complex exposes a nuclear localization sequence that facilitates nuclear 
translocation. This complex in turn binds 1[0 the aryl hydrocarbon receptor 
nuclear translocator (ARNT or HIF1~) in the nucleus resulting in DNA binding to 
sequences containing 5'-GCGGGGGCG-3' and (TCC)n repeats (Denison and 
Nagy, 2003). Translocation of the AHR-linand complex to the nucleus triggers its 
proteolytic degradation regardless of ARNIT binding (Roberts and Whitelaw, 
1999). Depending upon cell tYPE~, AHR can be regulated through negative 
feedback inhibition of AHR transcriptional activation by the AH repressor protein 
(AHRR) (Mimura et al., 1999). 
In mice, four distinct AHR alleles, AHb-1, AHb-2 , AHb-3, and A~f have been 
characterized (Poland et aI., 1994). C57BLl6J mice express A~-1 which 
encodes for the amino acid alanilne at codon 375 and results in a 5-fold higher 
ligand binding affinity (Kd=6-10pM) compared to DBAl2 mice (Kd=3?pM) which 
express the AH~ allele containing valine at codon 375 (Okey et al., 1989). The 
ala-val substitution results in a conformational change that substantially 
decreases ligand binding affinity without affecting association with HSP90. This 
renders the AHRd allele functionally null as exposure to ligand does not promote 
nuclear translocation, association with ARNT, AHRRE transcriptional activation, 
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or proteasomal degradation when compared to AHRb (Poland and Glover, 1990; 
Poland et aI., 1994). Accordingly, the con!~enic strain D2NA.hrd was developed to 
contain the exact genetic background as the C57BLl6J strain except for 
expression of the Af-fRd allele (Nebert et ai., 1972). Humans express AHR 
genetic polymorphic variants that alter AHIR function. Relevant to our studies is 
that expression of AHR protein with af!~/arg at codon 211 sinnificantly lowered 
birth weight and length in offspring exposed to in utero tobacco smoke (Sasaki et 
a/., 2006). Interestingly, variants of enzymes regulated by AHR activity (CYP1Al 
m1/m2 + m2/m2) or involved in PAH elimination (GSTM1 -/-) sensitized fetuses 
to the effects of maternal smokin!~ (Sasaki et al., 2006). This study directly links 
PAH exposure to deficits in AHR signaling in the context of fetal pronramming. 
Evidence continues to mount implicating AHR in the regulation of 
proliferation, development, adhesion and migration, and proteasomal 
degradation (for reviews see (Barouki et 61/.,2007; Ohtake et a/., 20(7)). Based 
on previous findings in our laboratory, as well as others, we hypothesized that 
AHR acts as an important nuclear transcription factor durin~~ embryogenesis and 
throughout maturity (Ramos et. aI., 2007). AHR-/- mice exhibit deficits in 
vascular structures stemming from a failure of the ductus venosus to close and 
result in reduced liver weight, microvesicular fatty metamorphosis, prolonged 
extramedullary hematopoeisis, and portal hypercellularity (Fernandez-Salguero 
et al., 1995; Lahvis et aI., 2000; Lahvis et al., 2005; Schmidt et al., 1996). Our 
laboratory has shown that AHR-l1ull mice exhibit delayed nl=phrogenesis resulting 
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in compromised renal development as evidenced by nephropenia and 
decreases in renal vasculature (Falahatpisheh and Ramos, 2003; McMillan and 
Bradfield, 2007b). These changes can be reproduced by decreased AHR protein 
levels upon ligand binding (Nanez and Ramos, 2007). In addition, AHR -/- mice 
were found to have endothelin1 and angiotensin II mediated cardiac hypertrophy 
and elevated mean arterial pressure, conditions directly linked to impaired renal 
functions (Gavras and Gavras, 2002; Lund et a/., 2003; Lund et al., 2006; 
Yamazaki et al., 1996). 
Using a metanephric kidney or9an culture system, our laboratory has 
shown that BaP exposure inhibits nephro!Jenesis as evidenced by decreases in 
branching morphogenesis, glomerular number, and decreases in undifferentiated 
cells. BaP-induced developmental deficits correlate with downregulation of renal 
cell differentiation markers and expression of the AHR. Here., we test the 
hypothesis that in utero exposure to BaP inhibits nephrogenesis through a 
mechanism involving ligand-mediated disruption of AHR signaling .. As an 
evolving role for AHR in developmental biology continues to unfold, this work will 
help to determine the mechanisms by which disruption of AHR signaling alters 
fetal programming within the context of exposure to environmental chemicals. 
Methods 
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In utero SaP exposure 
Time-pregnant C57BLl6J and B.6 D2N-AHRd/j females were exposed to 
BaP (Sigma-Aldrich, St. Louis, MO) or medium chain triglyceride oil (MCT) (Mead 
Johnson Nutritionals, Evansville, IN) at doses of 0.1 mg/kg and 0.5 mg/kg, 10 
through 13 d.p.c. by oral gavage. Murine in utero exposure of 150 mg/kg BaP is 
known to cause offspring T cell deficiencies (Lummus and Henningsen, 1995). 
Thus, the concentrations chosen for study were considerably lower than those 
established for in utero toxicity and terat0genecity (Lummus and Henningsen, 
1995; MacKenzie and Angevine, 1981 a; Hodriquez et al., 1999; Wells et aI., 
1997; Winn and Wells, 1997) and whE~n normalized for species-dependent 
temporal differences in development, are representative of human exposure of at 
risk populations (Menzie et aI., 1992a; Menzie et aI., 1992b; Rebagliato et aI., 
1995). 
Sources of human and animal PAH exposure include air, water, food, and 
soil and average 6·-15 I-lg/day (MenziE~ et al., 1992a; Menzie et al., '1992b). 
Depending on environment, food is thou~Jht to be the largest contributor. Active 
or passive smoking doubles PAH exposure to 30 I-lg/day (Santodonato et a/., 
1981). Assuming an average bodyweight of 60 kg, the average human intake is 
estimated to be 0.25 I-lg/kg/day to O.E) I-lg/kg/day for passive or active tobacco 
exposure. Allowing for differences in the length of mouse and human gestation, 
0.012 I-lg/kg/day is estimated as the predicted relevant murine exposure. While 
the 0.1 and 0.5 I-lgJkg exposure levels examined in our study are higher than 
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those encountered by the general U.S. human population, they are functionally 
relevant to human polymorphisms affectin!J PAH metabolism and AHR signaling 
(Sasaki et aI., 2006; Wong et al., 2001a; Vvong et al., 2001b), and'considerably 
lower than PAH levels examined in risk assessment studies of carcinogenicity 
and teratogenicity (Lummus and Henningsen, 1995; MacKenzie and Angevine, 
1981a; Rodriquez et aI., 1999; Wells et al., 1997; Winn and Wells, 1997). 
Seven days after birth, pups were Huthanized and renal tissue was fixed in 
situ. The heart, liver, testis, and aorta were extracted to assess system-specific 
effects of in utero BaP exposure. Pups from the same litter were monitored for 
12 months and examined for markers of nephropathy. 
Glomerular morphometric analysis and Immunohistochemistry 
Resected kidneys were fixed in fresh 4% paraformaldehyde at 4°C for 12 
hr and embedded in paraffin. 5~m sections were cut and processed, then 
stained with hematoxylin and eosin. For 'Immunohistochemical analysis, slides 
were treated under pressure with Vector Antigen Unmasking Solution® (Vector 
Laboratories, Burlingame, CA). WT1 (180) (Santa Cruz Biotechnology, Santa 
Cruz, CA) or AHR rabbit polyclonal (Biomollnternational, Plymouth Meeting, PA) 
antibodies were applied overnight at 4°C in a solution of 0.3% Triton X-1 00 and 
5% goat serum (Vector Laboratories, Burlingame, CA). Primary antibodies were 
bound to a goat anti-rabbit biotinylated secondary antibody (Invitrooen-Molecular 
Probes, Carlsbad, CA), amplified with ABCelite®, developed with 
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diaminobenzidine (DAB), and counterstained with Mayer's Hematoxylin (Vector 
Laboratories, Burlingame, CA). 
Glomerular numbers were quantified manually and verified by image 
analysis. For all analyses, images of entire kidney cross sections from 5 renal 
planes were captured at 20X. Using the Zeiss Axiovision Rei 4.3 .image analysis 
software, images of entire renal cross sections were filtered for intensity, color 
thresholding, and size of glomerular v\fT1 IHC signal allowing for distinction 
between glomeruli and other structures. Values were normalized to renal area 
in all instances. 
WT1 and AHR protein was measured by optimizing thresholding relative 
to negative control serial sections. Indices of protein expression were expressed 
as sum density normalized to total renal area. Podocyte number was quantified 
using WT1 signal filtered for intensity, color thresholding, and size. All values 
were normalized to glomerular number as measured by image analysis. 
Statistical significance was evaluated using SPSS statistical software 
(SPSS, SPSS Inc., Chicago, IL) and testing for significance between groups by 
analysis of variance (ANOVA) and least sum of square difference (LSD). 
Urinary albumin 
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Individual urine samples were collected and stored at -BODC in urine 
stabilizing buffer (Biotrin International, Dublin, Ireland). Under reducing 
conditions, 11..11 of urine sample was loaded on a 4-12% Bis-Tris NuPage gel 
(Invitrogen, Carlsbad, CA) and processed for silver staining as per 
manufacturer's instructions (Invitrogen, Carlsbad, CA). Sum density values were 
calibrated to a mouse serum albumin standard curve ranging from 10 to 0.001 
1..1 gl 1..1 I. 
Urinary Renal Papillary Antigen 1 (RPAl1) and Glutathione S-transferase 
Yb1 (GSTYb1) Measurements 
Enzyme immunoassays for the quantitative measurement of RPA 1 and 
GSTYb1 were performed as per manufacture's instructions (Biotrin International, 
Dublin, Ireland). Briefly, 96 well microtiter plates were supplied conjugated with 
anti-RPA1 or GSTYb1 IgG. Urine was diluted 1/25 and equilibrated for 1 hr at 
room temperature before addition of antibody-enzyme conjugate. After substrate 
development, absorbance was read at 4!;Onm with 630nm as a refE~rence. 
Absorbance was normalized to internal controls and expressed as relative units. 
Analysis of WT1 Splice Variants 
Total RNA was extracted usin!~ TRlzol® and cDNA was synthesized using 
SuperScript II (Invitrogen, Carlsbad CA) as per manufacturer's instructions. 
Quantitative PCR using primers specific for WT1 isoforms was performed to 
detect differences in the ratio of WT1 splice variants (±KTS) and (±17aa) 
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(Falahatpisheh and Ramos, 2003; Falahatpisheh and Ramos, 2007). Primers 
were designed using Beacon Designer 5.1 to create amplicons from 150-300 
base pairs with an average melting temperature of 58°C. 
Western Blot Analysis of WT1 Prote,in Isoforms 
Protein was extracted using T PER reagent (Pierce, Rockford, IL) as per 
manufacturer's directions. Samples were run on 4-12% Bis-Tris NuPage gels 
(Invitrogen, Carlsbad, CA) under reducing conditions and transferred to a PVDF 
membrane where bound protein was detected using WT1 (180) rabbit polyclonal 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and a horseradish 
peroxidase-conjugated secondary antibody. Previous work in the laboratory has 
shown that differences in ±17aa mRNA splice variants can be resolved at the 
protein level via gel electrophoresis. 
Results 
Fetal SaP exposure alters renal development and function in offspring 
C57 and D2N mice had similar numbers of glomeruli at 7 day old (Figure 
1A). In utero exposure to both 0.1 and 0.5 mg/kg BaP caused a significant 
decrease in glomerular numbers in C:57 but not D2N (Figure 1A and B). 
Offspring kidneys of BaP-exposed dams exhibited a reduction in glomerular size 
and increases in undifferentiated cells compared to controls (Figure 1 B). D2N 
mice expressing the low affinity AHRC! allele were protected from BaP-induced 
glomerular deficits (Figure 1A and B). 
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Figure 1. SaP inhibits nephrogenesis via an AHR allele specific 
mechanism. Kidneys were resected from 7-day old C57 and D2N-AHRd mice 
exposed to either 0.1, 0.5 mg/kg BaP or MCT oil vehicle in utero. Tissue was 
fixed in 4% paraformaldehyde and processed for modified hematoxylin and eosin 
staining, to visualize differentiated StruictUI'eS. Serial sections were processed for 
immunohistochemical analysis of WT1: protein and counterstained with 
hematoxylin. Glomerular number was quantified manually and verified by image 
analysis. Images of entire kidney cross sl8ctions from varying renal planes were 
captured at 20X. Intensity and color thresholding for glomerular WT1 signal was 
modified to exclude both small and large artifacts approximating glomerular 
number then normalized to renal area. Accuracy was controlled for by manual 
analysis of random images. Statistical si!~nificance was calculated by ANOVA 
and LSD post hoc tests p < 0.05. Panels A and B, show that exposure to BaP 
decreases glomerular number in C57 mice via an AHR allele-specific 
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Albuminuria is a hallmark of renal nephropathy and a common clinical 
marker for the diagnosis of renal disease (Cameron and Blandford, 1966). In 
agreement with previous work, albumin was the most abundant protein present in 
mouse urine (Figure 2B) (Marshall and W'illiams, 1987). C57 and D2N mice 
excreted similar amounts of urinary albumin demonstrating that expression of the 
AHRd allele does not affect renal development in unstressed animals (Figure 2A). 
In utero BaP exposure resulted in dose-dependent increases in albuminuria, at 
12 months old, which were dependent upon expression of the responsive AHRb 
allele. Under these conditions, D2N mice were unaffected (Figure 2A and 2B). 
Fetal SaP exposure is associated with specific glomerular deficits 
The podocyte is a key re~Julator in glomerular basement membrane (GBM) 
homeostasis by lending support to the glomerular tuft and functioning as the chief 
filtration barrier (Abrahamson, 1987; Sariola et al., 1984). Podocytes produce 
the majority of the molecular structures necessary for GBM maintenance 
(Abrahamson, 1987). Murine podocyte division halts 7 days post birth. Thus, 
impaired renal development, injury, or de-generation of the podocyte population 
results in deficits affecting adult renal function specifically impairing glomerular 
filtration (Mundel and Kriz, 1995). Immunohistochemical quantification of 
podocyte number revealed no differences between C57 and D2N mice (Figure 
2C). Both 0.1 and 0.5 mg/kg in utero BaP exposure elicited decreases in 
podocyte numbers (Figure 2C). D2N mice did not display BaP-induced deficits in 
podocyte number, further suggE~sting the importance of ligand binding in BaP-
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Figure 2. BaP exposure induc.~s glomE~rular specific injury. Urine was 
collected from 12 month old offspring C57 and D2N-AHRd mice exposed to either 
0.1, 0.5 mg/kg BaP or MCT oil in utero. Proteins were separated on a 4-12% 
Bis-Tris gel and developed by silver stain. Albumin values were normalized to 
mouse serum albumin standard curve (10, 1, 0.1, 0.01, and 0.001 fJg/fJl) and 
statistical significance was calculated by ANOVA and LSD post hoc tests p < 
0.05. Panel A, BaP alters albumin urinary levels in C57 mice via a dose-
dependent, AHR allele-specific mechanism. Panel B, silver stain visualization of 
mouse urinary albumin in C57 miice exposed in utero to 0.5 mg/kg MCT oil or 
BaP. Panel C, Immunohistochemical analysis of podocyte number was 
quantified using WT1 signal filtered for intensity, color thresholding and size 
normalized to glomeruli number. BaP exposure results in AHR allele-specific 
decreases in podocyte numbers. Panel D, Immunohistochemical analysis of total 
WT1 signal quantified using WT11 normalized to podocyte number. BaP 
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induced deficits in nephrogenesis (Figure 2C). As expected, both 0 1 and 0.5 
mg/kg in utero BaP exposure decreased \NT1 protein expression in an AHR 
allele specific manner (Figure 20). WT1 is a known regulator of nephrogenic 
outcomes in humans and mice (Niaudet and Gubler, 2006). WT1 activity is 
chiefly regulated in cis by expression of specific mRNA ratios resulting from 
posttranscriptional modification (HohenstE~in and Hastie, 21006; Lee et al., 2002). 
Ongoing work will examine the effects of in utero BaP exposure on WT1 mRNA 
splice variant expression in C57 and 02N mice. 
Classical markers of nephropathy such as blood urea nitrogen, urinary 
creatinine, and albuminuria generally manifest in severely compromised kidneys 
(Mathieson, 2004). A new class of urinary markers has been developed to detect 
subtle renal injury that precludes gross nephropathy. Rat papillary antigen 1 
(RPA 1) and glutathione S-transferase Yb1 (GSTYb1) are markers of collecting 
duct and distal tubule injury, respectively (Falkenberg et al., 1996; Hildebrand et 
al., 1999; Kilty et al., 1998). RPA1 is specifically produced in the papillary 
collecting duct and is released into the urine upon exposure to classical renal 
toxins (Hildebrand et al., 1999). GSTYb1 is highly expressed in the distal and 
convoluted tubules of the murine renal tubules and is released into the urine 
upon injury (Eger et al., 1997; Sundberg et al., 1994a; Sundberg et al., 1994b). 
The low level in utero SaP exposure did not alter urinary HPA 1 or (JSTYb1 levels 
in either C57 or 02N mice (Figure 3). Taken together these findings indicated 
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Figure 3. BaP exposure does not induce collecting duct or distal tubular 
injury. Urine was collected from 12-month old offspring C57 and D:2N-AHRd 
mice exposed to either 0.1, 0.5 mg/kg BaP or MCT oil in utero. Absorbances 
from enzyme immunoassay detection of RPA1 and GSTYb1 were normalized to 
internal controls expressed as relative units. Statistical significance was 
calculated by ANOVA and LSD post hoc tests p < 0.05. Panels A an B, BaP 
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that in utero BaP-exposure results in renatl deficits consist!:mt with glomerular 
neph ropathy. 
In utero BaP exposure decreases AHR protein expression 
Consistent with known AHR biology, in utero exposure to BaP resulted in 
dose-dependent decreases in AHR protein in C57 (Figures 4A and B). Loss of 
receptor protein correlated with AHR variant-specific reductions in glomerular 
and podocyte number, as well as increased urinary albumin. These results 
suggest that environmentally relevant in utero BaP exposures are sufficient to 
activate AHR and in doing so, promote degradation, likely altering constitutive 
signaling. 
Discussion 
Extensive in utero exposure studies have identified PAHs as potent 
modulators of fetal development that exert teratogenic and embryotoxic effects, 
(Lummus and Henningsen, 1995; MacKenzie and Angevine, 1981 a; Rodriquez et 
al., 1999; Wells et aI., 1997; Winn and Wells, 1997). However, the subtle effects 
stemming from environmentally relevant Goncentrations of PAHs have yet not 
being characterized. The known differences in murine and human renal 
development make accurate comparisons of BaP exposure challenging. Our 
exposure regimen accounts for the normalization of species differences in renall 
developmental duration and approximates likely maternal exposures that are 
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Figure 4. AHR expression correlates with deficits in m~phrogenesis. 
Kidneys were resected from 7-day old C57 mice exposed to either 0.1, 0.5 mg/kg 
BaP or MCT oil in utero. Tissue was fixed in 4% paraformaldehyde and 
processed for modified Hematoxylin and Eosin staining, to visualize differentiated 
structures. Serial sections were processed for immunohistochemical analysis of 
AHR protein and counter stained with hematoxylin. AHR signal was calculated 
by creating a thresholded value for AHR signal accounting for nonspecific signal 
from negative control serial sections processed without primary antibody and 
primary antibody neutralized with blocking peptide. Sum density was normalized 
to area and statistical significance was calculated by ANOVA and LSD post hoc 
tests p < 0.05. Panels A and B show that exposure to BaP decreases AHR 
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functionally relevant to human polymorphisms affecting PAH metabolism and 
AHR signaling (Sasaki et a/., 2006; Wong et a/., 2001 a; Wong et at., 2001 b). 
Evidence is presented here that maternal exposure to BaP inhibits renal 
development in offspring via an AHR allele-specific mechanism characterized by 
decreases in glomerular and podocyte numbers that compromise ~llomerular 
filtration. Thus, the bioavailabity of PAHs presents a ready source for agents that 
can modify important early determinants of renal development. Specifically, the 
data shown here indicate that BaP exposures of 0.1 and 0.5 mg/kg inhibit murine 
nephrogenesis specifically in C57 but not D2N mice. These findings are in 
agreement with previous work demonstrating that repeated exposure to 
environmentally-relevant concentrations of BaP inhibit nephrogenesis of murine 
metanephric cultures as evidenced by decreases in the number of renal 
differentiated structures and molecular markers of cell differentiation 
(Falahatpisheh and Ramos, 2003; Nanez and Ramos, 2007). Classical studies 
used gross endpoints such as fertility, fetal resorptions, death and severe 
developmental gonadal and immune deficits (Harrison et a/., 1994; Lummus and 
Henningsen, 1995; MacKenzie and Angevine, 1981a; Nicol et a/., 1995; 
Rodriquez et a/., 11999; Wells et a/., 199"7; Winn and Wells, 1997). While our 
exposure regimen did not result in gross embryonic deficiencies, as measured by 
resorption, death, or morphological organ abnormalities, subtle BaP-induced 
differences become manifest as decreased glomerular numbers and 
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compromised renal function. These deficits are relevant to the development of 
adult onset renal dlisease (Sasaki et al., 2006; Zandi-Nejad et al., 2006). 
Our model in which maternal BaP insult results in decreases in podocyte 
number that impair glomerular filtration is strikingly similar to clinical 
manifestations seen in conditions such as focal segmental glomerulosclerosis 
(FSGS) or diabetic nephropathy (Hara et al., 2001; Hayden et a/., 2005; Kim et 
al., 2001; Wolf et al., 2005). Podocytes are terminally differentiated cells that line 
the glomerular basement membrane (GBM) acting as a filter-mediated size-
selectivity and must structurally encompass the entire glomerular surface with 
foot processes to maintain proper filtration (Wiggins, 2007). Podocytopenia 
results in denudation of the GBM that compromise glomerular function initiating a 
cycle of injury and continued podocyt1e loss leading to progressive renal failure. 
In fact, glomerulopathies are the most common causes of end-stage renal 
disease worldwide (Hricik et a/., 1998). The impact of in utero BaP exposure on 
other glomerular cell populations such as mesangial and endothelial cells 
remains to be determined. Of interest, are findings from in vivo studies in female 
Sprague-Dawley rats exposed by gavage to weekly 10 mg/kg BaP resulted in 
progressive elevations in total urinary protein, protein/creatinine ratios and 
microalbuminuria (Nanez et a/., 2005). The nephropathic response involved 
early reductions in mesangial cell nurnbers coupled to podocyte injury as 
evidenced by effacement of foot prooess1es. 
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Of importance to our work is the evidence linking PAH exposures to renal 
injury. In humans, strong associations have been reported between occupational 
aromatic hydrocarbon exposures and glomerular diseases (Hotz, 1994; 
Robertson, 1998), smoking and albuminuria in nondiabetic patients (Pinto-
Sietsma et al., 2000), and a higher risk of renal dysfunction and renal cancer 
(Sertazzi et al., 1989). Taken together with our findings, PAHs may affect renal 
development and may predispose offspring to further injury resulting from 
repeated exposure in adulthood. 
AHR signaling is implicated in SaP-induced toxicity as D2N mice 
expressing the nonresponsive AHRd alle'le are protected from nephrogenic 
deficits. Since the AHRd allele is functionally null and SaP-induced deficits 
correlate to AHR protein expression, it is likely that loss of the AHR protein and 
constitutive signaling regulates nephrogenesis irrespective of nuclear 
translocation, association with ARNT, or AHRRE transcriptional activation. AHR 
transcriptional activity is regulated by association of complexes including AHR-
ARNT, NF-kappa S, AP-1, and glucocorticoid, all of which participate in 
numerous signaling pathways potentially relevant to nephrogenesis. Our work 
has identified AHR as a regulator of the 'Nilms' tumor transcription factor, a 
master regulator that initiates genetic events regulating early nephrogenesis. 
Loss of the AHR through ligand activation, genetic mutation, or siRNA-mediated 
degradation results in dysregulation of \NT1 mRNA isoforms and loss of renal cell 
differentiation markers (Falahatpisheh and Ramos, 2003; Falahatpisheh and 
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Ramos, 2007; Nanez and Ramos, 2007). Recent studies have proposed that 
AHR acts as an E3 ligase associatingl with proteasomal complexes consisting of 
DDB1, ARNT, TBL3 and CUL4B promoting degradation of sex steroid hormone 
receptors (Ohtake et al., 2007). These findings suggest a scenario in which AHR 
regulates proteasomal degradation of factors necessary for renal development, a 
hypothesis that remains to be tested. 
Expression of AHR is conserved across vertebrate and invertebrate 
species, many of which are not normally exposed to classical aromatic ligands 
(Hahn, 2002; Hahn et al., 2006). Our findings showing a correlation between the 
loss of AHR expression and compromised development (Nanez and Ramos, 
20(7), are in agreement with deficits seen in AHR-/- mice. However, these 
findings are not consistent with decreased levels of AHR protein seen in D2N 
mice-treated with BaP in utero. Thus, the nature of molecular signaling events 
regulated by AHR remain to be established. Irrespective of this observation, the 
collective evidence supports the hypothesis that AHR acts as an important 
nuclear transcription factor during embryogenesis and throughout maturity in 
multiple organisms. AHR-/- mice exhibit deficits in vascular structures stemming 
from a failure of the ductus venosus to close and result in reduced liver weight, 
microvesicular fatty metamorphosis, prolonged extramedullary hematopoeisis, 
and portal hypercellularity (Fernandez-Salguero et al., 1995; Lahvis et al., 2000; 
Lahvis et aI., 2005; Schmidt et al., 1996). Of direct relevance to our studies are 
experiments in which AHR-/- mice were found to have cardiac hypertrophy and 
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elevated mean arterial pressure, conditions known to arise from compromised 
renal function (Lund et aI., 2003; Lund et aI., 2006). We have previously shown 
that AHR-/- mice exhibit delayed nephro~lenesis resulting in compromised renal 
development, as evidenced by nephropenia and decreasE~s in renal vasculature 
(Falahatpisheh and Ramos, 2003; McMillan and Bradfield, 2007b). Small 
interfering RNA (siRNA.) mediated degradation of AHR results in decreases in 
renal cell differentiation markers (Falahatpisheh and Ramos, 2007). The 
mechanisms by which AHR signaling regulates renal cell differentiation and 




AHR SIGNALING AND NEPHROGENESIS: A MUTANT AHR ALLELE 
PROTECTS THE DEVELOPING KIDNEY FROM HYDROCARBON-INDUCED 
DEFICITS IN RENAL CELLULAR DIFFERENTIATION 
Summary 
The molecular mechanisms governing ontogenesis are regulated by 
somatic and environmental factors in utero that activate or repress the 
expression of numerous genetic elements. The aryl hydrocarbon receptor (AHH) 
is an important ligand-activated nuclear transcription factor involved in the 
regulation of cellular differentiation. Environmental hydrocarbons acting as AHH 
ligands deregulate receptor signaling to induce deleterious developmental 
deficits in several organ systems, including the kidney. Using a metanephric 
kidney organ culture system we have shown that benzo(a)pyrene (BaP), an AHR 
ligand, inhibits nephrogenesis in embryonic day 11.5 (EII.!)) C57BLl6J (C57) 
mouse embryos and alters -KTS/+KTS VVT1 mRNA ratios after a consecutive 
four-day exposure. Because WT1 (Wilms' tumor suppressor-1) functions as a 
master switch in the re~Julation of renal cE~1I differentiation, here we tested the 
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hypothesis that modulation of AHR signaling by SaP medilates changes in WT1 
splice variant ratios and expression of downstream effectors of WT1 leading to 
deficits in nephrogenesis. The data show that altered WT1 mRNA ratios in 
C57SLl6J mice expressing the AHRb allele correlated with a reduction in the 
mRNAs of multiple WT1 transcriptional targets (Synd1, Pax2, Egfr and Rara), as 
well as downstream markers of renal cell differentiation (Sfrp1, Igf1 r, Igf2r, Wnt4, 
Lhx1, and E-·cad). Metanephroi from S6.D2N-AHRd/J mice expressing an AHFt 
variant allele of reduced ligand-binding affinity were spared deficits in renal cell 
differentiation following SaP treatment. \Ne conclude that SaP disrupts 
nephrogenesis in vivo by altering the expression of downstream Wf1 targets 
secondary to changes in the abundance of WT1 mRNA slPlice variants. These 
findings establish a link between WT1 and AHR signaling in the regulation of 
renal cell differentiation during the course of metanephric development. 
Introduction 
Embryonic development requires orchestration of temporally precise 
genetic events that culminate in the formation of a complete organism. The 
molecular mechanisms responsible for ontogenesis are regulated by 
environmental and somatic factors in utero that activate or repress the 
expression of numerous genetic elements. Recent studies have identified the 
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aryll hydrocarbon receptor (AHR) as an important nuclear transcription 'factor 
during embryogenesis and throughout maturity in multiple organisms. AHR is 
involved in the regulation of development of vascular structures and liver 
(Fernandez-Salguero et a/., 1995; Lahvis et a/., 2005; Schmidt et a/., 1996), with 
AHR-/- exhibiting cardiomegaly and hypertension, as well as renal and ocular 
deficits (Falahatpisheh and Ramos, 2003; Fernandez-Sallguero et a/., 1997; Lund 
et a/., 2003; Lund et a/., 2006; McMillan and Bradfield, 2007b). The discovery of 
endogenous substrates of AHR has further strengthened the hypothesis that 
AHR functions as a critical developmental regulator (McMillan and Bradfield, 
2007a). Potent environmental chemicals. acting as AHR ligands disrupt normal 
signaling to exert deleterious effects during embryonic development (Mackenzie 
and Angevine, 1981b; Ng et a/., 2006b; Ng et a/., 2006c; Shum et al., 1979; Yu et 
a/.,2(06). While the mechanism of AHR-mediated regulation of xenobiotic 
metabolism is well understood, the details of AHR function during development 
remain unclear. 
AHR is a transcription factor activated by hydrophobic aromatic 
hydrocarbons. Upon ligand binding, AHR dissociates from two molecules of the 
chaperone heat shock protein 90 (HSP90), and binds the X-associated protein 2 
(XAP2) and p32. The resulting complex exposes a nuclear localization sequence 
that facilitates nuclear translocation. This complex in turn binds to the aryl 
hydrocarbon receptor nuclear translocator (ARNT or HIF'l~) resulting in DNA 
binding to sequences containing 5'-GCGGGGGCG-3' and (TCC)n repeats 
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(Denison and Nagy, 2003). Translocation of the AHR-ligand complex to the 
nucleus triggers its proteolytic degradation regardless of ARNT binding (Roberts 
and VVhitelaw, 1999). AHR is also regulated by negative feedback inhibition in 
which the nuclear AHR complex activates transcription of the AHR repressor 
protein (AHRR) responsible for binding the xenobiotic response element (XRE) 
and preventing transcriptional activation by AHR (Mimura et al., 1999). 
A role for AHR in renal development was established in experiments 
showing that AHR-null mice exhibit deficits in renal condensation, appearance of 
differentiated structures and cellular proliferation (Falahatpisheh and Ramos, 
2007). Renal development proceeds in three morphologically distinguishable 
stages pronephros, mesonephros, and metanephros (Pohl et al., 2000). The 
kidney derives from the nephric ridge in the intermediate mE~soderm. The 
pronephric duct gives rise to the pronephros which elongates to form the Wolffian 
duct. The Wolffian duct develops into the ureteric bud setting thE! stage for the 
key event in nephrogenesis where mesonephric mesenchyme is stimulated to 
undergo condensation and mesenchymad-to-epithelial cell transition. A host of 
genes including, WT1, glial cell derived neuronal factor (GDNF) and bone 
morphogenic protein-7, are responsible for regulating this process (Kuure et aI., 
2000). While removing anyone of a host of proteins can result in impaired 
nephrogenesis, the molecular mechanisms involved haVE! yet to be fully 
characterized. 
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Of interest is the central role of Wilms' tumor suppressor gene (WT1) in 
nephrogenesis. WT1 encodes a Cisr His2 zinc fingered protein that functions via 
transcriptional regulation of target genes, including insulin-like growth factor II, 
syndecan-1, epidermal growth factor receptor and retinoic acid receptor-a 
(Hosono et aI., 1999). In addition to its role in tumorigenesis, WT1 is considered 
a "master switch" that regulates mesenchymal-to-epithelial differentiation during 
renal development (Avner, 1993). Visceral epithelial cells (podocytes) are the 
only cell type in adult kidney that retains 'WT1 expression. Homozygous WT1 -/-
mice do not develop normally, die in utero, and do not show differentiation of 
metanephric kidney from the existing pronephros (Kreidber~l et aI'., 1993b). WT1 
activity can be regulated in cis by different ratios of its own splice variants, or in 
trans by proteins such as bone marrow zinc finger 2 (BMZF:2) (Lee et al., 2002). 
Perhaps the most studied regulatory mechanism involves the formation of WT1 
±KTS splice variants. KTS splice variants originate from the insertion of a Iysine-
threonine-serine between the third and fourth zinc finger. The resulting change 
modifies the WT1 DNA binding specificity leading to activation and/or repression 
of target genes (Menke et al., 1998b). In humans, reduced WT1 +KTS mRNA 
isoforms result in severe kidney and gonad developmental deficits, collectively 
known as Frasier syndrome (Barbaux et al., 1997). Changes in exon 5 splice 
variants have also been associated with deficits in renal differentiation (Iben and 
Royer-Pokora, 1999). Addition of 17 amino acids in exon 5 creates an mRNA 
isoform that regulates transactivation (Wang et al., 1995). N-terminal residues 1-
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182 encode a dimerization region implicated in the regulatory mechanism 
exerted by dominant negative mutants (Englert et aI., 19915; Reddy et al., 1995). 
The regulation of renal cell differentiation is controlled by synchronized 
expression of multiple genes involved in control of the devellopmental 
programming. Sfrp1 is a mesenchymal marker expressed in the metanephric 
medullary and cortical stroma that acts as an inhibitor of the mesenchymal-to-
epithelial cell transition (Yoshino et al., 2001a). Igf2r is chiefly expressed during 
the early stages of nephrogenesis whereas Igf1 r is expressed ubiquitously 
throughout renal maturation (Dong Van Huyen et aI., 2003). Loss of function of 
either receptor compromises renal differentiation (Feld and Hirschberg, 1996). 
Wnt4 is expressed in the condensed mesenchyme specifically around the ureter 
tip and in pretubular aggregates (for review see (Vainio et al., 1999). Wnt4 
deficiency inhibits epithelial tubule development resulting in dysfunctional 
nephrons (Stark et a/., 1994). Lim-1 is a homeobox transcription factor essential 
for early kidney morphogenesis. Lim-1 is chiefly expressed in the ureteric bud, 
induced mesenchymal aggregates, and differentiated structures (comma and S-
shaped bodies) (Barnes et al., 1994; Karavanov et al., 1 SI98). Murine models 
with Lim-1 deficiency are born headless and without kidneys despite the 
presence of other organs (Shawlot and Behringer, 1995b). E-cad is a general 
marker of the mesenchymal-to-epithelial cellular transition and is expressed in 
the ureteric bud epithelium, distal tubule progenitor cells and the majority of 
differentiated tubular epithelium (Cho et al., 1998). 
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The present study was conducted to evaluate the role of AHR signaling in 
murine nephrogenesis. This work builds upon previous studies establishing a 
novel link between AHR and post-transcl'iptional regulation of WT1 
(Falahatpisheh and Ramos, 2003). Evidence is presented that the low affinity 
AHRd allele abrogates BaP-induced molecular changes in the developing kidney, 
including changes in WT1 splicing and expression of WT1 downstream effectors 
involved in regulation of renal cell differentiation. 
Methods 
Metanephric Culture 
Day 11.5 mouse embryos were surgically dissected from C57BLl6J AHRb 
wild type and B6.D2N-AHRd/J mice. Embryonic kidneys were dissected and 
cultured on 0.45 mm polyethylene trephalate cyclopore cell culture inserts 
(Fisher) for 1-4 days. The use of transparent membranes allowed for direct 
visualization of tissue by phase contrast microscopy. Kidney explants were 
maintained at the liquid-gas interface in a solution consisting of a 1: 1 mixture of 
Dulbecco's modified Eagle's medium (DIMEM) and F12 supplemented with 10% 
fetal bovine serum (FBS) and a 5X concentration of MITO serum extender 
(Becton Dickinson, Bedford MA). Explants were allowed to equilibrate for 1 day 
before initiation of experiments. Seven or more embryonic kidney explants from 
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4 dams were placed on individual inserts and exposed daily to 3 iJM BaP or an 
equivalent volume of DMSO with or without 20 nM a-napthoflavone for 1, 3, and 
4 days. The 3 iJM BaP dose is an environmentally relevant exposure that 
provides optimum activation of the AHR receptor (Bowes and Ramos, 1994). At 
the end of each time point, the explants were fixed in situ for evaluation. 
Cell culture 
mK4 cells were cultured in DMEIVI (Cellgro) supplE!mented with 10% fetal 
bovine serum (Atlanta Biologicals) and 1 % antibiotic-antimycotic (Gibco). Cells 
were seeded at staggered time intervals at an initial density of 40 cells/mm2 to 
adjust final densities in culture. After equilibration for 24 hours, cells were 
exposed 3 iJM BaP or DMSO for 9, 15, or 51 hours. 
Histology and Morphometric Analysisi 
Metanephroi were fixed in 4% paraformaldehyde at 4°C for 16 hours, 
immobilized in Histogel (Richard Allen Scientific) and embedded in paraffin. 4 
iJm serial sections were cut and processed for modified hematoxylin and eosin 
staining allowing for visualization of differentiated structures. Images of at least 5 
metanephroi per treatment group were eaptured at 5X with an Axiovert 200 
inverted microscope (Zeiss) and stored as .zvi files. Glomeruli, S-shaped, and 




AHR was detected using a rabbit polyclonal antibody (B-1) (Biomol) 
applied overnight at 4°C in a solution containing 0.3% Triton X and 10% goat 
serum (Vector Laboratories). Primary antibody was detected using a goat anti-
rabbit biotinylated secondary antibody (Molecular Probes), amplified with 
ABCelite®, developed with DAB, and counterstained with Mayer's Hematoxylin 
(Vector Laboratories). 
Quantitative peR 
Total RNA was extracted using TRlzol® and cDNA was synthesized using 
SuperScript II (Invitrogen, Carlsbad, CA) as per manufacturer's instructions. 
Quantitative PCR using primers specific for WT1 isoforms was performed to 
detect differences in the ratio of WT1 splice variants (±KTS) in response to AHR 
ligand treatment (Falahatpisheh and Ramos, 2003; Falahatpisheh and f~amos, 
2007). A" other primers were designed using Beacon DE~signer 5.1 to create 
amplicons from 150-300 base pairs with an average meltling temperature of 
55°C. 
si RNA 
Ambion Silencer Pre-designed siF~NA for AHR (162529 and 88685), WT1 
(18990 and 100360), and a scrambled negative control (#4635) were transfected 
using Fugene 6 (Roche, Indianapolis, IN). Briefly, 150 nM of each specific siRNA 
was incubated with transfection reagent daily and applied to cells seeded at a 
79 
density of 60 cells/mm2 for three days. Seventy-two hours after treatment, cells 
were harvested in situ for further analysis. 
Statistical Analysis 
Statistical significance was determined using Students t-test, ANOVA, 
Wilcoxon Rank Sums, LSD, and Tukey post hoc tests at the p<O.05 level. 
Results 
Deficits in metanephric differentiation by BaP are linked to AHR si~lnaling 
The activation of AHR signaling by BaP culminates in transcriptional 
activation/repression of target genes, and proteasomal dE~gradation of AHR 
protein (for reviews see (Denison and Nagy, 2003; Fujii-Kuriyama and Mimura, 
2005; Pocar et aI., 2005). To examine the role of AHR si~Jnaling in Bap··induced 
deficits in nephrogenesis, metanephric explants from C57'-AHRb (C57) and D2N-
AHRd (D2N) mice were challenged with 3 ~M BaP for 1, 3, or 4 days. C57 and 
D2N mice are isogenic strains that differ in AHR ligand binding affinity due to a 
single nucleotide substitution that replaces valine for alanine at codon 3'75 in the 
ligand binding domain resulting in a 5-fold reduction in ligand binding affinity 
(Poland et a/., 1994). Quantitative reverse transcriptase polymerase chain 
reaction (QRT-PCR) analysis of C57 metanephroi revealed time-dependent 
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induction of Cyp1a1 mRNA, while D2N metanephroi expressing the variant AHR 
allele showed a markedly abrogated response (Table 1). A 4-day BaP exposure 
resulted in compromised metanephric development (Figure 1A), as evidenced by 
decreased number of glomeruli (Figure 1 B), and predominance of lesser 
differentiated, comma and S-shaped bodies (Figure 1 C). To determine if ligand-
binding mediated deficits in renal cell differentiation, D2N mice expressing the 
AHRd allele, or a-napthoflavone (a-NF), a competitive inhibitor of the AHR ligand 
binding site, were tested. Interference with AHR-ligand interactions prevented 
BaP-induced deficits in renal differentiation. a-NF alone modulated renal 
development outcomes (Figlure 1 B). Immunohistochemical analysis showed a 
decrease in AHR protein after 4 days of BaP exposure in AHRb mice (Figures 2A 
& B). In sharp contrast, the abundance of AHRd was not influenced by 
hydrocarbon treatment (Figure 2A). The AHRd phenotype, or co-treatment with 
a-NF, prevented the loss of AHR protein, suggesting that modulation of 
nephrogenesis by BaP directly correlates with depletion of AHR protein. This 
finding is consistent with the hypothesis that AHR is required for renal 
developmental signaling, and that disruption of nephrogenesis requires AHR 
ligand binding, activation of AHR signaling, and protein degradation. 
Next, the expression of mesenchymal (Sfrp1) and epithelial (lgf1 r, Wnt4, 
Lhx1, and E-cad) markers of differentiation was monitored by QRT-PCR~ to 
determine if morphological deficits correlated with modulation of these genes. 
Markers of renal epithelial cell differentiation (lgf1 r, Wnt4, Lhx1, and E-cad) were 
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Table 1. E 11.5 metanephroi were resected from C57 and D2N-AHRd mllce and 
cultured on 0.45 ~rn inserts for 4 days in the presence of 3 ~M BaP or DMSO. At 
1, 3, and 4 days individual metanephroi were homogenized and processed for 
RNA isolation and cDNA synthesis. Quantitative peR was performed with 
values representing i1i1CT normalized fold change relative to DMSO control 
(dashed line). Variance represents standard deviation between no less than 6 
metanephroi per group. Statistical significance was calculated using a VVilcoxon 
rank sum. Cyp1 a1 mRNA was inudced.in a dose and time-dependent manner in 
both C57 and D2N mice but to a greater extent in C57. 
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Table 1. Cyp1a1 mRNA Expression 
C57 
DBA 
Normalized fold change 
Exposure (days) Irelative to DMSO Control 
1 154.34 ± 20.8 
3 455.09 ± 30.62 
4 730.00 ± 24.00 
1 1.82 ± 0.27 
3 12.44 ± 2.03 
4 39.49 ± 1.20 
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Figure 1. SaP inhibits nephrogenesis via an AHR alleh~-specific 
mechanism. E 11.5 (days post conception) metanephroi were resected from 
C57 and 02N-AHRd mice and cultured on 0.45 IJm inserts for 4 days in the 
presence of 3 IJM SaP or OI\llSO ± a-NF. At 4 days, metanephroi were fixed in 
4% paraformaldehyde and processed for modified hematoxylin and eosin 
staining to visualize differentiated structures. Panel A, BaP-exposed 
metanephroi show less morphologically distinct differentiated structures 
compared to C57 control. E)(pression of the AHRd allele in D2N mice abrogates 
BaP-induced deficits. Co-treatment with the competitive inhibitor a-NF also 
inhibited BaP effects. B, quantitation of number of glomeruli normalized to area 
from serial sections of no less than 6 metanephroi per group. C, quantitiation of 
comma and S-shaped bodies normalized to area. Statistical significance was 
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Figure 2. AHR expression correlates with nephrogenesis. E 11.5 
metanephroi were resected from C57 and D2N-AHRd mice and cultured on 0.45 
IJm inserts for 4 days in the presence of 3 IJM BaP or DMSO ± a-NF. At 4 days, 
metanephroi were fixed in 4% parafomaldeyde and processed for modified 
hematoxylin and eosin staining, to visualize differentiated structures. Serial 
sections were processed for immunohistochemical analysis of AHR protein and 
counterstained with hematoxylin. AHR si~lnal was calculated by creating a 
thresholded value for AHR signal accounting for nonspecific signal from negative 
control serial sections processed without primary antibody and primary antibody 
neutralized with blocking peptide. Sum density was normalized to area and 
statistical significance was calculated by ANOVA and LSD post hoc tests p < 
0.05. Panels A and B show that exposure tD BaP decreases AHR protein levels. 
Protein expression was similar in C57' and D2N metanephroi, however D2N or 0-
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induced to varying degrees relative to vehicle control after 1 day of BaP exposure 
(Figure 3A). In C57' metanephroi, Igf1 r, l~lf2r, Wnt4, Lhx1, and E-cad mRNA 
levels were decreased after 3 and 4 days of BaP treatment (Figure 3A) .. No time-
dependent changes in the expression of the mesenchymal marker Sfrp1 were 
seen in C57 mice where downregulation was seen at all time-points compared to 
vehicle (Figure 3A). Metanephroi expressin!~ the AHRd allele showed variable 
degrees of induction in Sfrp1, Igf1 r, Wnt4. and E-cad throughout the exposure 
and were spared reductions of all markers examined, except Lhx1 (Figure 3B). 
These results suggest that nephrogenic deficits induced by BaP require 
activation, and integrity, of AHR signaling. 
The AHR allele mediates disruption of WT1 mRNA splice variants by BaP 
Previous work established that exposure of C57 mouse metanephric 
kidney cultures to BaP for 4 days modulaltes the expression of -KTS/+KTS WT1 
mRNA variants (Falahatpisheh and Ramos, 2003). A 4-day BaP exposure of 
C5t' metanephroi rE~sulted in 3- and 7 -fold induction of +KTS and -KTS variants, 
respectively (Figures 4A and B). Expression of the +17aa or -17aa was not 
altered by BaP treatment (Figures 4C and D). Consistent with the known WT1 
transcriptional repressive activity, significant reductions in the relative expression 
of several WT1 targets including: Synd1, Pax2, Egfr, and Rara, were observed 
(Figure 4E). D2N-AHRd metanephroi exposed to 3 IJM BaP did not exhibit 
changes in any of the VVT1 mRNA splice variants (Figures 5A-D) or WT1 targets 
(Figure 5E), except for Rara where the pattern of gene re~lulation was reversed 
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Figure 3. BaP exposure downregulatel; markers of renal cell differentiation. 
E 1 '1.5 metanephroi were resected from C57" and D2N-AHRd mice and cultured 
on 0.45 IJm inserts for 4 days in the presence of 3 IJM BaP or DMSO. At 1, 3, 
and 4 days individual metanephroi were homogenized and processed for RNA 
isolation and cDNA synthesis. Quantitative PCR was performed with values 
representing .~~CT normalized fold change relative to DMSO control (dashed 
line). Variance represents standard deviation between no less than 6 
metanephroi per group. Statistical significance was calculated usinn a Wilcoxon 
rank sum. Panels A and B show, that at 4 days BaP exposure, significant 
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Figure 4. BaP-induced WT1 dysregulation correlates with loss of known 
WT1 targets. E 11 .. 5 metanephroi were resected from C57 mice and cultured on 
0.45 I-lm inserts for 4 days in the presence of 3 I-lM BaP or DMSO. On days 1, 3, 
and 4, individual metanephroi were homolgenized and processed for RNA 
isolation and cDNA synthesis. Quantitative peR was performed with values 
representing ~~CT -normalized fold changle relative to DMSO control (dashed 
line). Variance represents standard deviation between no less than 6 
metanephroi per group. Statistical significance was calculated using a Wilcoxon 
rank sum. Panels A-D, primers specific for each splice were used to compare the 
abundance of splice variants from BaP treated and DMSO control samples. No 
changes were seen in total WT1 mRNA expression. Panels A and B, Significant 
increases were seen in -KTS compared to +KTS after 4 days BaP exposure. 
Panels C and 0, no significant changes were seen in +17aa or -17aa isoforms. 
Panel E shows that downregulation of known \NT1 targets correlated with 
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Figure 5. SaP-induced WT1 dysregulation is AHR allele-specific. E 11.5 
metanephroi were resected from D2N-AHRd mice and cultured on 0.45 I-lm 
inserts for 4 days in the presence of 3 I-lM BaP or DMSO. On days 1, 3, and 4, 
individual metanephroi were homogenized and processed for RNA isolation and 
cDNA synthesis. Quantitative PCR was performed with values representing 
L1L1CT-normalized fold change relative to DMSO control (dashed line). Variance 
represents standard deviation between no less than 6 metanephroi per group. 
Statistical significance was calculated using a Wilcoxon rank sum. Panels A-D, 
primers specific for each splice were used to compare the abundance of splice 
variants from BaP treated and DMSO control samples. No changes were seen in 
total WT1 mRNA expression. Panels A - D, expression of the AHRd allele 
abrogates BaP-induced modulation of WT1 mRNA isoforrns in D2N mice. Panel 
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compared to the C57 strain. C57 metanephroi exhibited decreases in taurine 
transporter mRNA and these: changes were absent in D2N metanephroi exposed 
to BaP (compare Figures 4E and 5E). 
mK4 metanephric cells arE! sensitive tOI modulation of WT1 mRNA isoforms 
by SaP and other AHR ligcmds 
To develop a model amenable to molecular manipulation, mouse mK4 
cells derived from metanephric tissue WE~re exposed to 3 I-lM BaP as a function 
of time (Valerius et al., 2002). mK4 cells exhibited time-dependent induction of 
Cyp1 a1, with maximal effeclts seen 51 hr after hydrocarbon exposure (Figure 
6A). Sfrp1, Igf1 r, Igf2r, Wnt4, and E-cad were downregulated by BaP as a 
function of time (Figure 6B), with the most prominent effects seen for Sfrp1, Igf1 r, 
Wnt4 and E-cad. Interestinlgly, Sfrp1 and Lhx1, markers of the mesenchymal 
phenotype contain AHR response elements in their promoter regions (data not 
shown), and showed a biphasic response. Changes in markers of renal cell 
differentiation correlated with changes in +KTS and -KTS where 2- and 5-fold 
inductions in mRNA expression, respecbvely, were observed (Figures 7 A and B). 
The expression of the +17aa isoform exhibited a biphasic response, with 
induction seen at 9 and 15 hours and a return to baseline at 51 hours (Figures 
7C and D). As in the metanephric model, AHR protein loss (Figure 7E) and 
dysregulation of WT1 splice variants correlated with reductions in WT1 target 
mRNAs, as evidenced by reductions in Pax2, Egfr, and Rara at 51 hours of BaP 
exposure (Figures 7F). 
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Figure 6. mK4 cells are sensitive to BaP induced changes in differentiation 
markers. mK4 cells were seeded and exposed at various times to 3 ~M BaP or DMSO 
to allow for harvest at equal density. At 9,15, and 51 hours cells were processed for 
RNA isolation and cDNA synthesis. Quantitative PCR was performed with values 
respresenting ~~CT-normalized fold change relative to DMSO control (dashed line). 
Variance represents standard deviation amongst at least three biological replicates. 
Statistical significance was calculated using a Wilcoxon rank sum. Panel A shows that 
mK4 cells display classical CYPIAI profile induction with a maximal response at 51 
hours. Panel B shows that after 51 hours of BaP exposure mK4 cells downregulated 
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Figure 7. mK4 cells are sensitive to BaP induced modulation of WT1 
status. mK4 cells were seeded and exposed at various times to 3 IJM BaP or 
DMSO to allow for harvest at equal density. At 9, 15, and 51 hours cells were 
processed for RNA isolation and cDNA synthesis. Quantitative PCR was 
performed with values representing ~~CT -normalized fold change relative to 
DMSO control (dashed line). Variance represents standard deviation amongst at 
least three biological replicates. Statistical significance was calculated using a 
Wilcoxon rank sum. Panels A and B, 51 hours of BaP exposure induces -KTS. 
Panels C and D, +17aa is increased at 9 and 15 hours. Panel E, Western blot 
analysis of WT1 targets shows loss of protein for known \/\'T1 markers. Panel F, 
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To determine if nephrogenic deficits were seen with other AHR ligands, 
mK4 cells were challenged with varying concentrations of TeOO ranging from 0.1 
pM to 1 nM for 4S hours. Integrity of AHR signaling was confirmed by induction 
of eyp1a1 mRNA (Figure SA). Both 100 pM and 1 nM TeDO decreased AHR 
protein (Figures SB and e). Exposure to 100 pM TeOO reduced expression of 
differentiation markers Sfrp1, Igf1 r, Igf2r, and Wnt4 (Figure SO). The loss of 
differentiation markers correlated with altered expression of WT1 splice variants 
(Figure SE). WT1 target genes, Synd1, Pax2, Egfr, and Rara were also 
downregulated by TeOO exposure (Figure SF). 
Discussion 
Evidence continues to mount implicating AHR in proliferation, 
development, adhesion and migration, and proteasomal degradation (for reviews 
see (Barouki et al., 2007; Ohtake et aI., 2007)). In this regard, previous studies 
in this laboratory have shown that repeated exposure of cultured metanephros to 
3 IJM BaP results in significant impairment of metanephric development 
(Falahatpisheh and Ramos, 2003). Such deficits required AHR activation and 
appears to be linked to the protein degradation machinery of target cells in the 
developing kidney. While the E3 ligase activity of AHR has yet to be fully 
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Figure 8. Alternative AHR ligands moderate differentiation markers and 
WT1 status. mK4 cells were seeded and exposed to TCDD or vehicle for 51 
hours to allow for harvest at equal density. Cells were processed for RNA 
isolation, cDNA synthesis and protein analysis. Quantitative PCR was performed 
with values representing 1'11'1CT normalized fold change relative to OM SO control 
(dashed line). Variance represents standard deviation amongst at least three 
biological replicates. Statistical significance was calculated using a Wilcoxon 
rank sum. Panel A, dose-dependent Cyp1a1 mRNA inductlion. Panels Band C, 
western blot analysis reveals a dose-dependent loss of AHR protein. Panel 0, 
TCDD exposure results in loss of renal cell differentiation markers. Panel E, 
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characterized (Ohtake et al., 2007), AHR ubiquitination and degradation can 
occur both in the cytoplasm (Song and Pollenz, 2002), or upon nuclear 
translocation (Roberts and Whitelaw, 1999), and ARNT/ONA binding (Song and 
Pollenz, 2003). Mutation of the ligand binding domain in the AHRd allele 
decreases ligand binding affinity by 5-fold compared to AHRb and decreases 
nuclear translocation (Poland et a/., 1994), transcriptional activation and 
degradation upon ligand binding. Similarly, AHR antagonists, such as a-NF, do 
not induce the conformational changes necessary for translocation and/or 
degradation of AHRb (Henry and Gasiewicz, 2003). These relationships define a 
scenario in which constitutive AHR plays a regulatory role in renal development 
that is compromised upon ligand-mediated degradation of receptor protein. In 
fact, AHR-null mice exhibit delayed nephrogenesis and compromised renal 
development (Falahatpisheh and Ramos, 2003), and these changes can be 
reproduced by downregulation of AHR protein upon ligand binding. Of 
importance to the work presented here are studies in which AHR-null mice were 
found to be hypertensive, a condition that is directly related to deficits in renal 
function (Lund et al., 2003; Lund et aI., 2006). 
Our model detailing a constitutive function for AHR in regulation of 
nephrogenesis via WT1 is supported by the finding that prevention of AHR loss 
pharmacologically, or by the use of the genetically-resistant 02N strain, 
prevented renal developmental deficits in BaP-treated metanephros, and 
restored normal ratios of WT1 mRNA isoforms.. Mice overexpressing the -KTS 
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isoform have severely compromised renal development, evidenced by increased 
stromal tissue, decreases in tubular epithelium and glomerular tuft, and altered 
podocyte structure (Hammes et a/., 2001). While the exact molecular 
consequences resulting from alterations of the four abundant and biologically 
relevant isoforms of WT1 remain to be fully defined, it is well-established that the 
-KTS mRNA encodes a protein that participates in transcriptional activity, and 
that protein encoding +KTS mRNA associates with splicing factors (Davies et al., 
1998; Hastie, 2001). In both metanephros and mK4 cell cultures, BaP-induced 
increases in -KTS resulted in downregulation of differentiation markers, a finding 
consistent with the morphological deficits seen in -KTS transgenic mice. 
Restoring WT1 mRNA splice variant ratios via AHRd expression did not alter 
renal differentiation markers. Transgenic mice expressing solely +17aa WT1 do 
not exhibit gross renal nephropathy (Natoli et al., 2002), but have deficits in other 
organ systems such as the olfactory system (V'Jagner et al., 2005). 
The complexity of AHR functions in different transcriptional complexes 
such as the classical AHR- ARNT, NF-kappa B, AP-1, and !~Iucocorticoid 
receptor provides possible mechanisms for regulation of Wr1 splicing. Of these, 
the glucocorticoid receptor has been shown to associate with PGC-1, a known 
regulator of co-transcriptional splicing (Knutti et al., 2001). Another possibility 
involves direct binding of AHR to the WT1 promoter which contains two 
consensus AHR responsive elements within a regulatory region known to 
regulate transcription-coupled splicing events (Cohen et al., 1997). Ongoing 
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experiments are examining whether AHR binds to the WT1 promoter to alter the 
splicing machinery directly (Bentley, 2002), or indirectly by altering elongation 
efficiency (Eperon et al., 1988; Roberts et al., 1998). Because AHR itself 
associates with proteasomal complexes consisting of DDB1, ARNT, TBL3 and 
CUL4B, and has E3 ligase activity (Ohtake et al., 2007), AHR may also regulate 
proteasomal degradation of factors required for WT1 splicing. 
The reduction of selected renal differentiation markers seen in organ and 
cell culture is consistent with the loss of AHR protein mediated by BaP, TCDD, or 
small interfering RNA (data not shown). All markers examined play central roles 
in nephrogenesis. Lhx1-null mice do not progress past mesonephric 
development (Shawlot and Behringer, 1995a). Wnt4 is implicated in early 
nephron development and differentiation (Stark et aI., 1994). Inhibition of the 
Igf1 r impairs kidney growth, as evidenced by a reduction in nephrons and altered 
ureteric bud branching (Murphy and Barron, 1993; Wada et al., 1993). E-cad-null 
mice have decreased nephron number due to a failure of proper fusion of the 
metanephric mesenchyme to the ureteric bud (Mah et al., 2(00). Sfrp1, most 
likely through Wnt interactions, plays an important role in the mesenchymal to 
epithelial cell transition manifested during tubule formation and bud branching 
(Yoshino et a/., 2001 b). While these markers have yet to be examined in AHR-
null mice, the preservation of AHR expression and constitutive signaling via 
expression of AHRd or treatment with antagonist, restores their expression. 
These findings associate functional molecular consequences resulting from 
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disruption of constitutive AHR functions with the regulation of renal cell 
differentiation. 
The discovery of novel functions of AHR during nephrogenesis, coupled to 
molecular interactions of AHR with WT1, highlight a potential mechanism for 
compromised renal development following AHR signaling interference. The 
bioavailability of PAHs presents a ready source for agents that can modify 
important early determinants of renal cell differentiation. Of importance to our 
work are studies linking AHR genetic polymorph isms to tobacco smoke induced-
decreases in birth weight (Sasaki et a/. , 2006). Low birth weight compromises 
renal development resulting in increases in microalbuminuria, proteinuria, 
decreased glomerular filtration rate, and the occurrence of end stage renal 
disease (for review see (Zandi-Nejad et al., 2006)). Other stressors, such as diet 
and environmental exposures, are associated with lower birlth weights and 
deficits in renal development (Everson et al., 1988; Nelson ot al., 1999; Roquer 
et al., 1995; Zandi-Nejad et al., 2006). Preliminary findings indicate that 
exposure of pregnant C57 dams to BaP to environmentally-relevant 
concentrations, inhibits renal development (Nanez, et ai, unpublished). 
The present studies identify a novel role for AHR in the regulation of 
murine nephrogenesis. Expression of the AHRd allele preserves the integrity of 
AHR signaling and abrogates hydrocarbon-induced dysregulation of WT1 mRNA 
isoforms thus preserving renal cell differentiation signals. Thus, endogenous and 
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exogenous modulators of AHR signaling during critical periods of nephrogenesis 
may alter the genetic programming of renal development. 
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CHAPTER 4 
LOSS OF THE ARYL HYDROCARBON RECEPTOR PROTEIN ALTERS WT1 
mRNA ISOFORM EXPRESSION AND DOWNSTREAM EFFECTORS OF 
RENAL CELL DIFFERENTIATION 
Summary 
A key event in nephrogenesis is the transdifferentiation of mesenchymal 
cells to epithelial cells, a tightly regulated process controlled by the Wilms' tumor 
transcription factor (WT1). WT1 activity can be regulated in cis by different ratios 
of its mRNA splice variants, or in trans by accessory proteins recruited to 
regulatory regions of the gene. Recently, a novel link between AHR and post-
transcriptional regulation of WT1 isoform expression was characterized in this 
laboratory. The aryl hydrocarbon receptor (AHR) is an important ligand-activated 
nuclear transcription factor involved in the regulation of cellular differentiation. 
AHR-null mice exhibit systemic developmental deficits including nephropenia. 
Previous work has shown that exposure to environmental hydrocarbons that 
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function as AHR ligands deregulate receptor signaling via proteasomal 
degradation and induce receptor-specific deregulation of WT1 mRNA splice 
variant ratios in murine metanephric organ and cell. This work led us to 
hypothesize that disruption of receptor signaling following loss of AHR protein 
results in WT1 dysregulation thereby altering expression of WT1 targets and 
renal cell differentiation genes. Evidence is presented here showing that AHR 
degradation mediated by small interfering RNA results in downregulation of +KTS 
and induction of the -KTS mRNA splice variants. WT1 dysregulation correlates 
with reductions in WT1 transcriptional targets (Synd1 Pax2, Egfr and Rara), as 
well as downstream markers of r€!nal cell differentiation (Sfrp1, Igf1 r, Igf2r, Wnt4, 
Lhx1, and E-cad). We conclude that AHR regulation of nephrogenesis occurs 
through preservation of WT1 mRNA isoform ratios within the kidney. 
Introduction 
The aryl hydrocarbon receptor (AHR) is a member of the basic helix loop 
helix Per ARNT Sim (bHLH-PAS) family of transcription factors and initially 
characterized for its role in the re!~ulation of xenobiotic metabolizing enzymes 
(XMEs) necessary for removal of exogenous chemicals. VVhile bHLH-PAS 
proteins share similar structure and function, the AHR is the only member of the 
family known to be regulated by ligand activation. Environmental chemicals such 
as polycyclic aromatic hydrocarbons act as AHR ligands leading to the 
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dissociation of two molecules of the chaperone heat shock protein 90 (HSP90), 
X-associated protein 2 (XAP2) and p32. The resulting conformational change in 
AHR exposes a nuclear localization sequence that facilitates nuclear 
translocation. In the nucleus, AHR dissociates from the chaperone complex and 
binds the aryl hydrocarbon receptor nuclear translocator (ARNT) resulting in 
association of the major groove DNA sequence cantaining 5'-GCGGGGGCG-3' 
and (TCC)n repeats (Denison and Nagy, 2003). Translocation of the AHR-ligand 
complex to the nucleus can also trigger its proteolytic degradation regardless af 
ARNT binding (Roberts and WhitE~law, 1999). Depending upon cell type, AHR 
can be regulated by negative feedback inhibitian in which the nuclear AHR 
complex activates transcription of the AHR repressor protein (AHRR) respansible 
for binding the xenobiotic response element (XRE) (Mimura et a/., 1999). AHR 
transcriptional activity is regulated by association of complexes including AHR-
ARNT, NF-kappa B, AP-1, and glucocorticoid receptor all of which, in turn, 
participate in numerous signaling pathways potentially relevant ta nephrogenesis 
(Abbatt et al., 1994; Hankinson, 2005; Hoffer et al., 1996; Miller et al., 2000; Tian 
et al., 2002). 
Of relevance to this study are novel links identifying AHR as a regulator af 
the Wilms' tumor transcription factor (WT1), a master switch transcriptianal 
regulatar which initiates genetic E~vents necessary for early nephrogenesis 
(Scharnhorst et al., 2001). Loss Df the AHR through ligand activation, genetic 
mutation, or siRNA-mediated degradation results in dysregulation of WT1 mRNA 
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isoforms and loss of renal cell differentiation markers (Falahatpisheh and Ramos, 
2003; Falahatpisheh and Ramos, 2007; Nanez and Ramos, 2007). Studies using 
AHR -/- mice have led to findings that support the scenario in which AHR acts as 
an important nuclear transcription factor during embryogenesis and throughout 
maturity in multiple organisms. AHR -/- mice exhibit cardiac hypertrophy and 
elevated mean arterial pressure (Lund et aI., 2003; Lund et aI., 2006) that 
correlate to inductions in endothelin-1 and angiotensin II, known regulators of 
cardiomyocyte hypertrophy and hypertension (Gavras and C3avras, 2002; 
Yamazaki et al., 1996). Of relevance to renal biology is that angiotensin II is a 
potent renal vasoconstrictor that constricts efferent arterioles and increases 
blood pressure. Our laboratory has shown that AHR-null mice exhibit delayed 
nephrogenesis resulting in compromised renal development as evidenced by 
nephropenia and decreases in renal vasculature (Falahatpisheh and Ramos, 
2003; McMillan and Bradfield, 2007b). Thus, it is possible that developmental 
renal deficits in AHR -/- mice stem from disruption of AHR signaling implicit in 
nephrogenesis. 
Nephrogenesis proceeds in three morphologically distinguishable stages 
pronephros, mesonephros, and metanephros (Pohl et al., 2000). The precursor 
structure for renal development derives from the nephric ridge in the intermediate 
mesoderm. The pronephric duct gives rise to the pronephros which elongates to 
form the Wolffian duct. The Wolffian duct develops into the ureteric bud 
stimulating the mesonephric mesenchyme to undergo condensation and 
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transdifferentiate from mesynchemal-to-epithelial cells. A cascade of genetic 
events regulated by proteins including WT1, glial cell derived neuronal factor 
(GONF) and bone morphogenic protein-7, are responsible for regulating this 
process (Kuure et aI., 2000). While homozygous deletion or mutation of either of 
these genes impairs nephrogenesis, the molecular mechanisms involved have 
yet to be fully characterized. 
WT1 encodes a Cis2-His2 zinc fingered protein that functions via 
transcriptional regulation of target genes, including insulin-like growth factor II 
(lgf2r), syndecan-1 (Synd1), epidE~rmal growth factor receptor (Egfr) and retinoic 
acid receptor-a (Rara) in the early stages of renal development (Hosono et al., 
1999). Homozygous WT1-/- mice do not develop normally, die in utero, and fail 
to differentiate into metanephric kildney from the existing pronephros (Kreidberg 
et al., 1993b) due to a failure of cE~lIs to undergo mesenchymal-to-epithelial 
differentiation (Avner, 1993). WT1 protein expression is strongest in the 
differentiating structures of the developing kidney; however, visceral epithelial 
celis (podocytes) are the only cell type that retains WT1 expression in mature 
kidneys. 
Of importance to the present work is that WT1 activity is regulated in cis 
by different ratios of its own splice variants, or in trans by proteins such as bone 
marrow zinc finger 2 (BMZF2) or Pax2 (Lee et a/. , 2002). Perhaps the most 
studied regulatory mechanism involves the formation of WT1 +KTS/-KTS splice 
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variants. KTS splice variants originate from the insertion of a Iysine-threonine-
serine between the third and fourth zinc finger. The resulting change modifies 
the WT1 DNA binding specificity leading to activation and/or repression of target 
genes (Menke et a/., 1998b). In humans, reduced WT1 +KTS mRNA isoforms 
result in severe kidney and gonad developmental deficits, collectively known as 
Frasier syndrome (Barbaux et aI., 1997). Changes in exon 5 splice variants have 
also been associated with deficits in renal differentiation (Iben and Royer-Pokora, 
1999). Addition of 17 amino acids in exon 5 creates an mRNA isoform that 
regulates transactivation (Wang et aI., 1995). N-terminal residues 1-182 encode 
a dimerization region implicated in the regulatory mechanism exerted by 
dominant negative mutants (Englert et aI., 1995; Reddy et aI., 1995). We 
propose that disruption of AHR si~Jnaling resulting from receptor degradation 
deregulates WT1 resulting in an induction in the -KTS mRNA splice variant, thus 
altering the sequence of genetic events necessary for nephrogenesis. 
Evolutionary comparison has shown that the Ahr is conserved across 
vertebrate and invertebrate species, many of which are not exposed to classical 
aromatic ligands (Hahn, 2002; Hahn et a/., 2006). Evidence is mounting to 
support the idea that AHR functions as a key regulator of ontogenesis. In this 
study we demonstrate that degradation of the AHR results in dysregulation of WT 
mRNA splice variant ratios resulting in downregulation of direct genetic VI/T1 




C57BLl6J wild type mice were purchased from Jackson Laboratory (Bar 
Harbor, Maine) and placed under standard housing conditions. The care, 
breeding, and handling of animals were conducted in accord with NIH guidelines. 
Kidneys were resected, fixed in 4(1'0 paraformaldehyde, and embedded in 
paraffin. 
Immunohistochemistry 
WT1 (180) (Santa Cruz Biotechnology, Santa Cruz, CA) and AHR rabbit 
polyclonal antibodies (Biomol Research Laboratories Inc., Plymouth Meeting, 
PA) were applied overnight at 4°C in a solution containing 0.3% Triton X and 
10% goat serum (Vector Laboratories, Burlingame, CA). Primary antibody was 
detected using a goat anti-rabbit biotinylated secondary antibody (Molecular 
Probes), amplified with ABCelite@, developed with diaminobenzidine (DAB) and 
3, 3', 5, 5'-tetramethylbenzidine (TMB), respectively (Vector Laboratories, 
Burlingame, CA). Images were captured on a Zeiss Axiovert 300 microscope 
using Axiovision Rei 4.3 software interface (Carl Zeiss Inc .. Maple Grove, MN). 
Cell Cultures/ siRNA Transfectiion 
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mK4 cells were kindly provided by Dr. Stephen Potter (Children's Hospital 
Medical Center, Cincinnati, OH). Cells were cultured in Oulbecco's modified 
Eagle's medium supplemented with 10% fetal bovine serum. Two different 
techniques were used for siRNA knockdown of AHR and v\fT1 targets. 1) mK4 
cells were cultured and seeded at 30 cells/mm2 in 6 well plates. Using 
OharmaFECT 2, mK4 cells were transfected with 150nM pooled siRNA AHR (10# 
L-044066-00-0005), WT1 (10# L040686-01-0005) or nonspecific sequence. After 
4 days, cells were harvested for RNA isolation, cONA synthesis, and protein 
extraction. 2) Hairpin siRNA was designed using verified Silencer Pre-designed 
siRNA directed towards AHR (10#188990) and WT1 (10# 100360). The resulting 
structures were cloned into a pSilencer 4.1 CMV hygro vector (Ambion, Austin, 
TX) and transfected into mK4 cells using Fugene 6. pSilencer 4.1 CMV hygro 
Negative Control (Ambion) was used to measure nonspecific effects. Stalbly 
transfected cells were selected for using 800 I-lg/1-l1 hygromycin over a 3 week 
period. Cells were harvested for I~NA isolation, cONA synthesis, and protein 
extraction. 
Protein Extraction and Western Analysis 
Total protein extraction was performed with M-PER reagent (Piercl~ 
Biotechnology, Rockford, IL) as described by the manufacturer. Protein 
concentration was normalized to bovine serum albumin and measured by 
Bradford analysis. Protein samples were heated at 70°C for 10 minutes and run 
on 4-12 % NuPage ® Bis-Tris gels for one hour at 200 volts (Invitrogen, 
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Carlsbad, CA). Proteins were transferred to PDVF membranes and probed with 
WT1 (180) (Santa Cruz Biotechnology, Santa Cruz, CA) and AHR rabbit 
polyclonal antibodies (Biomol Research Laboratories Inc., Plymouth Meeting, 
PA). Signal was visualized with secondary antibodies conjugated to horseradish 
peroxidase developed by SuperSignal® West Dura (Pierce Biotechnology, 
Rockford, IL). Values represent averages of at least three independent 
experiments. 
RNA Isolation and Real time peR Amplification 
Total RNA was extracted from the cells using Trizol® according to 
manufacturer's specifications. Reverse transcription of RNA was carried out 
using iScript™ cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Real time PCR 
amplification was performed using the iCycler Detection System (Bio-Rad, 
Hercules, CA). For each run, 25 1-11 of 2X SYBR Supermix (Bio-Rad, Hercules, 
CA) and 300 nM for both forward and reverse primers in a total volume of 50 1-11 
were mixed. Quantitative PCR using primers specific for WT1 isoforms was 
performed to detect differences in the ratio of WT1splice variants (±KTS) as 
follows. -KTS forward 5'-AGCTCAAAAGACACCAAAGGAG-3', reverse 5'-
GGGCTTTTCACCTGTATGAG-3'; +KTS reverse 5'-
GAAGGGCTTTTCACTTGTTTTAC-3'; -17 aa 5' -CCTGAGGACGCCCT ACAG C-3' 
reverse 5'-TGTGCCGTGGCCCTTT AAGG-3'; + 17 aa 5'-
CTGTGCCGTGGTTGCTCTGC-3'. All other primers were designed using 
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Beacon Designer 5.1 to create amplicons from 150-300 base pairs with an 
average melting temperature of 55°C depicted in Table 1. 
Quantification was performed using comparative (LlCT) method as 
described by Peinnequin et al. (2004). Briefly, the Cr indicates the fractional 
cycle number for which the amount of amplified target reaches a fixed threshold. 
This amount is a constant depending on the primer set. The difference (ACT) 
between the CT of the target gene (CTt) and the reference gene (CTr) depends on 
the RNA relative copy number between the target and the reference gene. When 
the PCR have been properly optimized, the PCR efficiencies are close to one 
and the amount of target (XN), normalized to an endogenous reference is given 
by the equation: XN = K x T ilcT WE~re K is a constant according to the target and 
reference primer sets (Lestaevel E~t aI., 2003). The normalization to a calibrator 
(188 RNA) allows reduction of the previous equation by removing the constant K. 
Under these conditions, the amount of target normalized to an endogenous 
reference and relative to a calibrator (XN,c) is given by the equation: XN,c:= ZMCT 
where LlLlCT is the difference between the LlCT of the sample and the LlCT of the 
calibrator. The LlCT method is based on i) similar amplification efficiency rates 
between target and reference genes and ii) PCR efficiency close to 1. 
Matrigel Cell culture 
mK4 cells were cultured in Dulbecco's modified Eagle's medium 
supplemented with 10% fetal bovine serum and 5X mito serum extender (Becton 
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Table 1: peR Primers 
Gene Forward Primer 5'-3' 
Gene Forward Primer 5'-3' Reverse Primer 5'-3' 
18S CGTCTGCCCTATCAACTTTCG GCCTGCTGCCTTCCTTGG 
Cyp1a1 ~CGTGTCAGTAGCCAATGTC GCATCCAGGGAAGAGTTAGG 
Taurine Transporter CATCCATCGTCATTGTGTC ~GTTGGCAGTGCTAAGG 
Syndecan 1 GAGAAC~AGACTTCACCTTTG ~GCACTTCCTTCCTGTCC 
Paired box gene 2 (pax2) IAGGTTT ACATCTGGTCTGG TAGGAAGGACGCTCAAAG 
Epidermal growth factor 
GAGGAGGAGAGGAGAACTG GGTGGGCAGGTGTCTTTG 
receptor (Egfr) 




sequence protein 1 GCAGTTCTTCGGCTTCTA ATGGAGGACACACGGTTG 
(Sfrp1 ) 
Insulin-like growth factor I 
GTCCCTCAGGCTTCATCC GAGCAGAAGTCACCGAATC 
receptor (Igf 1 r) 





integration site 4 (Wnt4) 
Lim homeobox protein 1 
~CCTAAGCAACAACTACAATC ~CACGGGAGTAGAAAGC 
(Lhx1) 
E-Cadherin CGACCCTGCCTCTGAATCC CTTTGTTTCTTTGTCCCTGTTGG 
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Dickinson, San Jose, CA). Cells were seeded at 200 cells/mm2 in 6 well cell 
culture dishes coated with 500 1-11 of Matrigel® (Becton Dickinson, San Jose, CA) 
Fresh media was added every three days. Renal bodies were harvested after 
two weeks for further analysis in situ. 
Analysis of glomerular bodies was performed by seeding mK4 cells in 6 
well cell culture dishes coated with 100 1-11 of Matrigel® in Dulbecco's modified 
Eagle's medium supplemented with 10% fetal bovine serum lacking 5X mito 
serum extender. After 4 days cultures were fixed in 50:50 Acetone methanol and 
processed for immunocytochemistry using WT1 rabbit polyclonal (180) and 
Thy1.1 mouse monoclonal antibodies visualized by goat anti rabbit 488 and goat 
anti-mouse 568 AlexaFluor (Molecular Probes-Invitrogen, Carlsbad, CA). 
WT1 expression vectors and selection 
pSRV plasm ids containing all four WT1 splice variants from the 17aa/KTS 
sites including WT1A(-I-), WT1 B(+/-), WT1 C(-I+), and WT1 D(+/+) were created 
as described by Haber et al. (Haber et al., 1992). WT1 sequences were excised 
with Bglli and inserted into p3XFLAG-CMV-14 expression vector (Sigma-Aldrich, 
St. Louis, MO). mK4 cells were transfected with 1 I-Ig of each splice variant and 
control vector. mK4 cells expressing vector derived gene products were selected 
for with Geneticin® treatment (Inviitrogen, Carlsbad, CA). WT1 splice variant 
overexpression was verified by QRT-PCR. 
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Results 
AHR and WT1 colocalize in developing and adult glomeruli 
AHR protein is a ubiquitous protein expressed primarily in lung, thymus, 
liver, gut mucosa, kidney, and urogenital tissue (Jain et al., 1998). 
Immunohistochemical (lHe) analysis revealed ubiquitous expression of the AHR 
throughout all parts of renal tissw:; with strongest signals occurring in glomeruli 
and endothelial cells of major renal vascular structures (Figures 1 A, B, and e). 
DuallHe analysis for AHR and \/\IT1 was employed to determine cellular 
specificity and colocalization. In adult glomeruli, the strongest AHR signal 
colocalized with WT1 staining in the podocyte population (Figures 2A and B). In 
glomeruli of developing metanephros, AHR and WT1 colocalization occurs in the 
majority of the cell populations (Figures 1 e and D). This pattern is consistent 
with the known role for WT1 in mesenchymal-to-epithelial cell transition and the 
emerging role for AHR in renal dE!velopment (Falahatpisheh and Ramos, 2003; 
Falahatpisheh and Ramos, 2007; Nanez and Ramos, 2007; Scharnhorst et aJ., 
2001 ). 
siRNA-mediated Degradation of AHR Downregulates Renal Cell 
Differentiation Markers 
We have previously shown that exposure of metanephric organ cultures to 
BaP, an environmental hydrocarbon that acts as an AHR ligand, inhibits 
nephrogenesis in a manner dependent upon AHR protein expression 
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Figure 1. AHR expression in adult mouse kidney. AHR expression is highest 
in epithelial celis of renal vasculature and in glomerular podocytes. 
Immunohistochemical analysis of AHR protein as visualized by 3, 3'-
diaminobenzidine (DAB) staining of formalin-fixed paraffin-embedded adult 
mouse kidney sections. In Panel A, AHR signal (brown color) localizes to the 
celis lining the renal vasculature. Panels Band C compare AHR and WT11 
signal, respectively in adult glomeruli. Intense AHR signal (denoted by arrows) 
shows patterns indicative of podocyte expression when compared to WT1 signal. 
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Figure 1 
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Figure 2. AHR colocalizes with WT1 expression. AHR and WT1 colocalize in 
the developing and adult kidney. Dual immunohistochemical analyses of AHR 
and WT1 proteins visualized using 3, 3', 5, 5'-tetramethylbenzidine (TMB) and 
NovaRED, respectively. Panels A and C are representative images taken of 
glomeruli from adult C5"7BLl6J mouse kidneys or E11 cultured metanephros 
cross-sections. In panel B, maximal AHR signal (blue color denoted by arrow) 
was measured using Zeiss Axiovision Rei 4.3 image analysis software. Positive 
AHR signal is outlined in red. AHR-WT1 colocalization was defined by a positive 
nuclear WT1 signal in proximity to the outlined AHR signal, as denoted by 
arrows. Because of the diffuse nature of the AHR signal throughout metanephroi 
in panel D, AHR-WT1 colocalization was determined by overlay of AHR and 
WT1signals. Normalized signal was always <10% in sections stained separately 
with individual antibodies. Panels E and F are serial cross sections of C57BLl6J 
E11 cultured metanephroi analyzed for AHR alone or AHR-WT1 colocalization as 
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(Falahatpisheh and Ramos, 2003; Falahatpisheh and Ramos, 2007; Nanez and 
Ramos, 2007). In this model, BaP binds AHR resulting in nuclear translocation 
thus promoting transcription of AHRE containing xenobiotic metabolizing 
enzymes, and culminates in proteasomal degradation of AHR protein. To 
determine the effects of AHR degradation irrespective of ligand activation, mK4 
cells of metanephric cell lineage were exposed to pooled siRNA directed against 
AHR. Seventy two hour siRNA exposure resulted in loss of AHR protein and 
mRNA (Figures 3A, B, and C). Exposure to AHR siRNA and subsequent loss of 
AHR protein resulted in downregulation of Igf1 r, Wnt4, Igf2r, and E-cad as 
determined by quantitative RT-PCR (QRT-PCR) (Figure 3D). The mesenchymal 
marker Sfrp1 and Lhx1 did not change (Figure 3D). To determine if constitutive 
AHR degradation altered markers of renal cell differentiation, we examined mK4 
cells expressing the pSilencer 4.1 CMV hygro vector containing a sequence that 
when transcribed produces a 19-mer hairpin with a loop and 3' terminal overhang 
that is processed by cellular machinery to produce siRNA (vsiRNA) (Paddison et 
al.,2002). After selection with hygromycin, cell populations expressing AHR 
vsiRNA exhibited reductions in AHR protein and mRNA (Figures 4A, B, and C). 
Constitutive AHR degradation resulted in decreased expression of Sfrp1, Igf1 r, 
Igf2r, Lhx1 and E- cad mRNA (Figure 4D). However, unlike conventional siRNA, 
AHR vsiRNA resulted in an induction of \Nnt4 and reductions in Sfrp1 and Lhx1. 
These differences may be due to separate functionally redundant transcriptional 
pathways activated after prolonged AHR degradation. 
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Figure 3. siRNA-mediated degradation of AHR downreglulates renal cell 
differentiation markers. mK4 cells were cultured and seeded at 30 cells/mm2 in 
the presence of 150 nM pooled siRNA targeted for AHR or a nonspecific 
sequence for 3 days. Cells were processed for RNA isolation, cDNA synthesis, 
and protein extraction. Quantitative PCR was performed with values 
representing ~~CT-normalized fold change relative to DMSO control (dashed 
line). Variance represents standard deviation between at least three biological 
replicates. Statistical significance was calculated using a Wilcoxon rank sum. In 
panels A-C, siRNA directed towards AHR results in loss of I\HR protein and 
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Figure 4. Vector-mediated siRNA degradation of AHR downregulates renal 
cell differentiation markers. mK4 cells were seeded at 50 cells/mm2 and 
transfected with vectors containing siRNA sequences targeted for WT1 or a 
nonspecific. After two weeks selection with hygromycin, mK4 populations 
containing stable siRNA expression were processed for RNA isolation, cDNA 
synthesis, and protein extraction. Panel A and 8, Western blot analysis of AHR 
protein normalized to a-tubulin loading control. siRNA directed towards AHR 
results in loss of AHR protein. Panel C and D, Quantitative PCR was performed 
with values representing LlLlCT-normalized fold change relative to DMSO control 
(dashed line). Variance represents standard deviation between at least three 
biological replicates. Statistical significance was calculated using a Wilcoxon 
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siRNA-mediated Degradation Induces -KTS WT1 mRNA and Downregulates 
Direct WT1 Transcriptional Targets 
Our next set of experiments examined whether AHR degradation was 
solely responsible for WT1 dysregulation. Using QRT-PCR, we measured 
relative amounts of -KTS and +KTS WT1 mRNA, as well as, known WT1 
transcriptional targets directly regulated by WT1 (Synd1 Pax2, Egfr, Rara, TauT) 
(Han and Chesney, 2003; Ryan et al., 1995; Saxen, 1987; Vainio et aI., 1999). 
Both siRNA and vsiRNA-mediated AHR degradation resulted in an induction in -
KTS and reduction in +KTS (Figures 5A, B, C, and D). In agreement with the 
known role of -KTS WT1 as a transcriptional suppressor (Menke et al., 1998a), 
AHR siRNA resulted in decreased expression of known targets Synd1, Pax2, 
Egfr, Rara , and TauT (Figure 5E). Constitutive vsiRNA-mediated AHR 
degradation resulted in selective downregulation of Synd1, Egfr, and TauT 
(Figure 5F). In contrast to siRNA, AHR vsiRNA did not alter Pax2 and induced 
Rara (Figure 5F). These results implicate a pathway whereby disruption of AHR 
signaling via protein degradation shifts WT1 mRNA isoform ratios towards -KTS 
resulting in functional changes in known WT1 transcriptional targets. 
siRNA-mediated Degradation of WT1 Downregulates Direct Transcriptional 
Targets and Renal Cell Differentiation Markers 
To compare the molecular consequences of elevated -KTS mRNA to loss 
of WT1 protein, mK4 cells exposed to WT1 siRNA were examined for mRNA 
expression of renal cell differentiation markers and known WT1 targets. WT1 
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Figure 5. Loss of WT1 protein correlates with -KTS induction and target 
gene downregulation. In panels A, 8, and E, mK4 cells were cultured and 
seeded at 30 cells/mm2 in the presence of 150 nM pooled siRNA targeted for 
WT1 or a nonspecific sequence for 3 days. Cells were processed for RNA 
isolation and cDNA synthesis. Quantitative PCR was performed with values 
representing ,1.,1.CT-normalized fold change relative to DMSO control. Variance 
represents standard deviation between at least three biological replicates. 
Statistical significance was calculated using a Wilcoxon rank sum. siRNA 
directed towards AHR resulted in --KTS induction and +KTS reductions that 
correlated to loss of WT1 target Synd1, Pax2, Egfr, Rara and TauT mRNA 
expression. In panels C, 0, and F, mK4 cells were transfected with vsiRNA 
directed towards AHR. vsiRNA selection resulted in cell populations with 
induced expression of -KTS and decreased expression of +KTS. WT1 targets 
Synd1, Egfr and TauT were downregulated while Pax2 remained unchanged and 
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siRNA resulted in downregulation of WT1 protein and mRNA (Figures 6A and B). 
Similar to results seen with AHR siRNA-mediated -KTS induction, loss of WT1 
protein resulted in downregulation of renal cell differentiation markers Sfrp1, 
Igf1 r, Igf2r, Wnt4, and E-cad (Figure 6C). Lhx1 remained unchanged (Figure 
6C). WT1 siRNA reduced mRNA expression of the WT1 transcriptional targets 
Synd1, Pax2, Egfr, and Rara (Figlure 60). 
Overexpression of WT1 mRNA Isoforms Downregulates WT1 Ttarge!t Genes 
To determine the effects of specific WT1 isoforms on WT1 target genes, 
cONA sequences containing the four variants -17aa/-KTS (WT1A), -17aa/+KTS 
(WT1 C), and +17aa/+KTS (WT1 D) were cloned into a p3XFLAG-CMV-14 
expression vector. mK4 cells stably expressing the vector were selected with 
G418 and assayed for molecular endpoints of WT1 and target gene expression. 
Figures 7 A-O shows confirmatory evidence that selected populations specifically 
expressed WT1A, WT1 B, and Wf1 0 mRNA isoforms in amounts significantly 
higher than empty vector. Compared to empty vector, expression of WT1 A, C 
and 0 resulted in downregulation of Synd1, Pax2, Egfr, and Rara mRNA as 
evidences by QRT-PCR (Figures 7E and F). Although splice variant-specific 
expression of WT1 protein was not measured, the data indicate that the amounts 
of WT1 proteins produced by CMV promoter-driven overexpression are sufficient 
to downregulate WT1 targets, re~lardless of mRNA isoform. 
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Figure 6. siRNA-mediated degradation of AHR down regulates renal cell 
differentiation markers. mK4 ceilis were cultured and seeded at 30 cells/mm2 in 
the presence of 150 nM pooled siHNA targeted for WT1 or a nonspecific 
sequence for 3 days. Cells were processed for RNA isolation, cDNA synthesis, 
and protein extraction. Quantitative PCR was performed with values 
representing i1i1CT normalized fold change relative to DMSO control (dashed 
line). Variance represents standard deviation between at least three biological 
replicates. Statistical significance was calculated using a Wilcoxon rank sum. In 
panels A and 8, siRNA directed towards AHR results in loss of AHR proteiin and 
mRNA. In panel C, WT1 siRNA results in downregulation of the differentiation 
markers Sfrp1, Igf1 r, Igf2r, Wnt4, and E-cad. In panel D, WT1 siRNA results in 
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Figure 7. Overexpression of WT1 mRNA isoforms downregulates Wlr1 
targets. P3XFLAG-CMV-14 exprE~ssion vectors containing all four WT1 splice 
variants from the 17aa/KTS sites including WT1A(-/-), WT1 8(+/-), WT1 C(-/+), 
and WT1 0(+/+) were transfected into mK4 cells. mK4 cells expressing vector 
derived gene products were selected by antibiotic resistance and examined for 
expression of WT1 splice variants by QRT-PCR, panels A, 8, C, and D. Panels 
E and F, overexpression of WT1 constructs downregulates 'NT1 targets Synd1, 








.~ 3.0E-02 , 
~ 
4i 2.SE-02 · 
... 2.0E-02 
· (I) 
co 1.5E-02 , ,... 
ill 1.0E-02 
-r-







.~ B.OE-03 i 
4i 60E-03 ... 
(I) 
























































Empty WT1 A WT1 C WT1 0 
Vector 
·1.4E-02 -

















Synd1 Pax.2 Egfr RaRo 
i 0 Empty 
• WT1 A (--) 
,0 WT1 C (-+) 
.• WT1 0 (++) 
-------------- - . 
142 
Matrigel Induces Formation of Metanephric Structures in mK4 Cells 
To develop an in vitro model better-suited to examine the effects of WT1 
splice variants on nephrogenesis, mK4 cells were seeded on Matrigel, a matrix 
known to induce differentiation and aggregation of various cell types into 
structures reminiscent of in vivo tissue ( for review see (Schmeichel and Bissell, 
2003)). Culture of mouse mammary epithelial cells in matrigel promotes the 
formation of morphologically distinctive mammary alveoli which, in response to 
lactogenic hormones, produce milk (Li et al., 1999; Lin and Bissell, 1993; 
Sympson et al., 1994). The data shown in Figures SA-C show that after 4 days 
in culture, mK4 cell cultures developed aggregates resembling metanephric 
bodies that closely resembled developing kidneys resected from E15 embryos 
(Figure SO). Removal of mito serum extender from the media resulted in a 
typical cell culture monolayer with a ring of cellular growth that contained bodies 
morphologically resembling glomeruli (Figure 9A). Immuncytochemistry for 
markers specific for glomerular podocytes (WT1) and mesangial cells (Thy 1.1) 
revealed positive staining in glomerular structures (Figure 9B, C, and 0). 
Collectively these data indicate that upon stimulation by matrix-related factors, 
nascent cell lines derived from metanephric cell cultures can provide a useful 
model for studying the molecular genetics of nephrogenesis. 
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Figure 8. mK4 cells cultured on Matrigel form metanephric aggregates. 
mK4 cells were cultured in full media plus mito serum extender in 6 well cell 
culture dishes coated with 500 IJI of Matrigel®. Panels A -C, metanephric renal 
bodies developed after 4 days of culture and showed morphological similarities to 






Figure 9. mK4 cells cultured on Matrigel form glomerular specific 
structures. mK4 cells were cultured in full media in 6 well cell culture dishes 
coated with 100 IJI of Matrigel®. After 4 days, cultures were processed for 
immunocytochemical identification of glomerular markers. WT1 rabbit polyclonal 
(180) and Thy1.1 mouse monoclonal antibodies were visualized by goat anti-
rabbit 488 and goat anti-mouse 568 AlexaFluor. Panel A, DAPI stained nuclei 
form a monolayer ring of cells around the outer portion of the cell culture we" with 
morphologically visible glomeruli. Panel B, C, and 0, WT1 signal (green) and 









The emergin!g role for AHR in nephrogenesis is intriguing and emphasizes 
the need to understand the complexity of AHR signaling beyond xenobiotic 
metabolism (Falahatpisheh and Ramos, 2003; Fernandez··Salguero et a/., 1995; 
Lahvis et a/., 2000; Lahvis et al., 2005; McMillan and Bradfield, 2007b; Schmidt 
et a/., 1996). Previous work in this laboratory has shown that exogenous ligands 
of the AHR inhibit m~phrogenesis via a mechanism requiring conservation of 
AHR signaling and preservation of WT1 mRNA splice variant ratios and 
expression of renal cell differentiation markers (Falahatpisheh and Ramos, 2003; 
Falahatpisheh and Ramos, 2007; Nanez and Ramos, 2007'). 
In the present study we show that disruption of AHR signaling is linked to 
the protein degradation machinery of tanJet cells in the developing kidney and 
results in disruption of genetic signaling implicit in nephrogenesis. AHR 
ubiquitination and degradation occurs both in the cytoplasm (Song and Pollenz, 
2002), or upon nuclear translocation (Roberts and Whitelaw, 1999), and 
ARNT/DNA binding (Song and Pollenz, 2003). However, members of the 
proteasomal compl18!x and the series of events leading to degradation have yet to 
be fully characterized. Recent work has shown that AHR functions as an E3 
ligase and associates with proteasomal complexes consisting of DDB1, ARNT, 
TBL3 and CUL4B in the degradation of steroid sex receptors (Ohtake et a/., 
2007). Thus, it is likely that AHR participates in an auto-regulatory loop that 
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promotes proteasornal degradation. In fact, the ubiquitin E3 ligase Itch, a family 
member of the Nedd4/Rsp5p HECT domain-containing family has been shown to 
participate in auto-ubiquitination facilitating its own proteasomal degradation 
(Mouchantaf et al., 2006). 
siRNA-mediated reduction in AHR protein results in a decrease of renal 
markers of differentiation in agreement with pharmacological models of AHR 
degradation (Nanez and Ramos, 2007). This is the first known report indicating 
that a reduction in AHR protein is sufficient to disrupt expression of molecular 
markers necessary in nephrogenesis. \tVnt4 is implicated in early nephron 
development and di1ferentiation (Stark: et al., 1994). Sfrp1, most likely through 
Wnt interactions, plays an important role in the mesenchymal to epithelial cell 
transition manifested during tubule formation and bud branching (Yoshino et al., 
2001 b). Lhx1-null mice do not progress past mesonephric development (Shawlot 
and Behringer, 1995a). Inhibition of the Igf1 r impairs kidney growth, as 
evidenced by a reduction in nephrons and altered ureteric bud branching 
(Murphy and Barron., 1993; Wada et at., '1993). E-cad-null mice have decreased 
nephron number due to a failure of prope!r fusion of the metanephric 
mesenchyme to the ureteric bud (Mah et aI., 2000). Conservation of AHR 
expression and constitutive signaling via expression of the nonresponsive AHRd 
allele, which does not degrade upon ligand binding, or treatment with antagonist, 
maintains expression of renal cell differentiation markers (Nanez and Ramos, 
2007). These findin9s associate functional molecular consequences resulting 
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from disruption of constitutive AHR functions with the regulation of renal cell 
differentiation. 
We have shown that siRNA-mediated degradation of AHR results in 
induction of the -KTS WT1 mRNA splice variant. Depending upon cell type and 
stimulus, AHR functions in a diverse array of transcriptional complexes including 
the classical AHR-ARNT, NF-kappa B, AP-1, and glucocorticoid receptor which 
provide possible mechanisms for regulation of WT1 splicing. Of these, the 
glucocorticoid receptor has been shown to associate with PGC-1, a known 
regulator of co-transcriptional splicing (Knutti et al., 2001). Another possibility 
involves direct binding of AHR to the major groove of the WT1 promoter which 
contains two consensus AHR responsive elements within a regulatory region 
known to rE~gulate transcription-coupled splicing events (Cohen et aI., 1997). 
Determining the exact nature of AHR-WT1 promoter interactions and possible 
effects on splicing machinery directly (Bentley, 2002) or indirectly by altering 
elongation efficiency (Eperon et al., 1988; Roberts et al., 1998) remains an 
ongoing focus of the laboratory. 
Our findings demonstrating inductlion in -KTS secondary to the loss of 
AHR are consistent with in vivo studies in which mice overexpressing the -KTS 
isoform have severely compromised renal development, evidenced by increased 
stromal tissue, decrE~ases in tubular epithelium and glomerular tuft, and altered 
podocyte structure (Hammes et al., 2001). This is in agreement with previous 
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work from the laboratory showing that in utero BaP exposure results in offspring 
with reduced glomerular number and glomerular filtration due to podocytopenia 
While the exact molecular consequences resulting from alterations of the four 
abundant and biolo~~ically relevant isoforms of WT1 remains to be fully defined, it 
is well-established that the -KTS mRNA encodes a protein that participates in 
transcriptional activity, and that the protein encoded by +KTS mRNA associates 
with splicing factors (Davies et a/., 1998; Hastie, 2001). In both metanephros 
and mK4 cell cultures, BaP-induced shifts in -KTS WT1 mRNA resulted in 
downregulation of differentiation markers, a finding consistent with the 
morphological deficits seen in -KTS transgenic mice and in our in utero exposure 
study. On!Joing studies will focus on the molecular consequences resulting from 
overexpression of each 17aa/KTS WT1 splice variant in the context of renal cell 
differentiation gene regulation. 
Downregulation of WT1 protein did not induce WT1 targets for negative 
regulation. It is possible that -50% WT1 knockdown was not sufficient to ablate 
WT1 negative regulatory activity. Since \NT1 siRNA is not isoform specific, we 
assume that mRNA splice variant ratios were unchanged and that the negative 
regulatory role for -KTS is mediated more by the relative abundance of mRNA 
isoforms than by the total amount of protein expressed. Ongoing studies will use 
vector mediated WT1 siRNA to achieve more efficient degradation of specific 
variants. 
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The development of an organ culture model system has been an 
important tool for discovery the molecular mechanism of ontogenesis. However 
incompatibility with assays necessary for further mechanistic discovery led us to 
examine alternative approaches. Extensive work carried out to recreate 
vasculature, kidney, lung, skin, and mammary tissue using 3D matrices has 
shown the promise and utility of 3D cultures in molecular biology (Sakurai et aI, 
1997; Schmeichel and Bissell, 2003; Schuger et al., 1990). Our model of 
Matrigel induced metanephric body formation agrees with the known role of 
extracellular matrices (ECM) from both the ureteric bud and the metanephric 
mesenchyme in ureteric branching morphogenesis. ECM protein expression is 
tightly regulated via growth factor signaling pathways which in turn are regulated 
by master switch transcription factors. Laminins compose the majority of the 
mature basement membrane,and have been shown to participate in branching 
morphogenesis and tubulogenesis (Engel, 1993). Exposure to anti-laminin5 
blocking antibody inhibits renal development of cultured metanephroi by 
preventing association with Q3f31 and Q6f34-integrin receptors (Zent et aI., 2001). 
In addition, cells stemming from the ureteric bud must digest ECM proteins to 
facilitate invasion. Both matrix metalloproteases (MMPs) and serine proteases 
are known to facilitate renal development. Membrane-type matrix 1 (MT-1-MMP) 
and MMP-2 oligonucleotide antisense inhibits metanephric development 
dependent on the TIMP-2 inhibitor activity (Kanwar et al., 1999; Ota et al., 1998). 
Thus, it is likely that renal morphogenesis requires elements secreted in the ECM 
to initiate biological events necessary for the initial and continued progression of 
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nephrogenesis. The extent to which AHR participates in the regulation of cell-
matrix interactions in the developing kidney remains to be established. Work by 
others has shown that expression regulates members of the MMP and laminin 
families (Hillegass et al., 2006) and we recently established a gene network 
where AHf~ interacts closely with osteopontin and other matrix-associated 
proteins (Johnson et aI., 2004). 
The present studies further define a novel role for AHR in the regulation of 
murine nephrogenesis. AHR expression is a key regulator of WT1 mRNA splice 
variant homeostasis. Loss of AHR results in dysregulation of WT1 manifest in 
inductions of -KTS and downregulation of WT1 targets and markers of renal cell 
differentiatilon. The matrix-dependent stimulation of mK4 cells into metanephric 
tissue may provide a useful model for examination of the molecular events 




Although WT1 has been widely studied with respect to renal development 
and oncogenesis, many questions remain unanswered. The majority of work to 
date has focused on putative WT1 targets and correlations between splice 
variant expression and clinical outcomes in vivo (for review see (Niaudet and 
Gubler, 2006)). A major gap in our knowledge is the limited amount of 
information available about the putative factors that regulate splicing. Our work 
demonstrating that loss of AHR expression results in -KTS mRNA induction 
suggests AHR as putative regulator of WT1 mRNA splicing. This is in agreement 
with our in utero studies where BaP exposure results in offspring with reduced 
glomerular number and glomerular filtration due to podocytopenia. While the 
exact molecular consequences resulting from alterations of the four abundant 
and biologically relevant isoforms of WT1 remains to be fully defined, it is well-
established that the -KTS mRNA encodes a protein that paliicipates in 
transcriptional activity, and that protein encoding +KTS mRNA associates with 
splicing factors (Davies et al., 1998; Hastie, 2001). In both metanephros and 
mK4 cell cultures, Bap··induced shifts in -KTS resulted in downregulation of 
differentiation markers, a finding consistent with the morphological deficits seen 
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in -KTS transgenic mice and in our in utero exposure study. Ongoing work will 
utilize constructs of all four KTS/17aa WT1 mRNA splice variants expressed in 
cells of varying differentiation status to begin defining the mechanism by which 
WT1 regulates the genetic cascade necessary for renal development. Our data 
implicate the participation of AHR signaling in WT1-mediated regulation of 
nephrogenE~sis. 
Of direct importance to our work is the emerging role of AHR in renal 
development. Studies have shown roles for AHR in cell proliferation, adhesion 
and migration, all processes necessary for embryogenesis (for reviews see 
(8arouki et 08/., 2007; Ohtake et al., 2007)). The Ramos laboratory has shown 
that AHR-/- mice exhibit delayed nephrogenesis resulting in compromised renal 
development as evidenced by nephropenia and decreases in renal vasculature 
(Figure 1) (Falahatpisheh and Ramos, 2003; McMillan and Bradfield, 2007b). 
We have also shown that these changes can be reproduced by proteasomal 
decradation of AHR protein upon ligand binding .. While our work has chiefly 
focused on \NT1 dysregulation at the posttranscriptionallevel as a key 
mechanism by which AHR exerts regulatory influences, little is known about 
other possible mechanisms that may contribute to deficits in nephrogenesis, such 
as direct transcriptional regulation of renal cell differentiation markers or 
participation in proteasomal degradation of renal regulatory proteins (Figure 2). 
A major theme of this dissertation revolves around the developmental 
deficits associated with disruption of WT1 signaling and differentiation resulting 
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Figure 1. AHR-/- mice exhibit deficits in renal development with 
consequE!nCeS in adult kidney morphology. Hematoxylin and Eosin stain of 
developing mouse metanephros shows that AHR-/- have less developed 
embryonic kidneys. Latex cast of AHR-/- adult kidneys have less vascularization 















Figure 2. Schematic detailing the complexity of possible mechanisms by 
which Ahr may regulate WT1. Transcriptional activity may directly regulate 
splicing factors. AHR may participate in proteolytic degradation of factors implicit 
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from the loss of AHR protein. In our earlier work, exposure of wild type 
metanephros to BaP leading to nephrogenic deficits similar to those seen in 
untreated AHR-/- metanephros implicated AHR as a regulator of renal 
development (Falahatpisheh et al., 2005). In agreement with known renal 
deficits in AHR-/- mice, Chapters 1 and 2 used in vivo and in vitro models to 
show that loss of AHR protein expression correlated with the downregulation of 
renal cell differentiation markers, and WT1 dysregulation. This is the first report 
showing that loss of AHR protein, regardless of biological context following ligand 
binding, is sufficient to disrupt expression of molecular markers implicit in 
nephrogenesis. To date, most studies implicating AHR in the development of 
liver, cardiovascular, and reproductive organs have shown strong correlations for 
AHR involvement, but lack any direct evidence of interactions with downstream 
effectors responsible for disruption of organ development (Fernandez-Salguero 
et al., 1995; Lahvis et al., 2000; Lahvis et al., 2005; Lund et aI., 2003; Lund et a/., 
2006; Schmidt et aI., 1996). Our discovery of AHR-dependent regulation of WT1, 
a known renal master switch transcription factor, is the first study to propose a 
direct mechanism for the role of AHR in ontogenesis (Figure 3). 
A theme consistent in all of our studies is that loss of the AHR induced by 
BaP, TCDD, siRNA AHR exposure, or genetic manipulation in AHR-/- mice 
(Falahatpisheh and Ramos, 2007) results in the downregulation of known 
markers of renal cell differentiation Sfrp1, Lhx1, Igf1 r, Igf2r, Wnt4, and E-cad 
(Barnes et aI., 1994; Cho et aI., 1998; Dong Van Huyen et al., 2003; Stark et al., 
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Figure 3. Conceptual framework for AHR regulation of nephrogenesis. 
Constitutive AHR signaling regulates WT1 function allowing for normal 
nephrogenesis. Exogenous AHR ligands in the form of PAHs initiates a 
response that results in WT1 dysregulation as evidenced by changes in the 
amounts of mRNA splice variants that ultimately disrupt the cascade of genetic 




1994; Vainio et al., 11989; Yoshino et al., 2001b). While the involvement of WT1 
in the regulation of targets such as Wnt4 (Sim et aJ., 2002) have been previously 
made, the mechanisms by which loss of AHR protein downregulates target gene 
expression remain unknown. 'Wnt4 is limplicated in early nephron development 
and differentiation, and has been identified as a possible re~~ulator of AHR 
transcription in prostate cancer cells (Chesire et aJ., 2004; Stark et aI., 1994). 
This suggests a possible scenario in which loss of AHR results in WT1 
dysregulation and subsequent downregulation of Wnt expression leading to 
generalized disruption of protranscriptional signals derived from Wnt/beta-catenin 
signaling and further loss of AHR protein. Sfrp1, through Wnt antagonistic 
interactions, plays an important role in the mesenchymal-to-·epithelial cell 
transition during tubule formation and bud branching. Sfrp1 contains AHRRE 
elements in the regulatory region, suggesting the AHR may also regulate Wnt 
signaling via Sfrp1 transcriptional control (Yoshino et al., 2001 b). In a similar 
manner, the inhibition of the 1~lf1 r impairs kidney growth, as evidenced by a 
reduction in nephrons and altered ureteric bud branching (Murphy and Barron, 
1993; Wada et aJ., 11993). Activation of the Igf1 r necessitates binding of 
extracellular insulin growth factors (IGF), a process that is tightly regulated by a 
family of proteins named insulin growth factor binding protein (IGFBP). AHR is a 
known regulator of IGFBP expression and may alter Igf1 r activity through 
induction of IGFBP proteins (Johnson et aI, 2004; Marchand et al., 2005). 
Perhaps the best marker of renal epithelial cell differentiation is E-cad as 
transition from mesenchymal to epithelium results in increased expression of this 
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critical epithelial gene (Cho et a/., 1998). E-cad-null mice have decreased 
nephron number due to a failure of proper fusion of the metanephric 
mesenchyme to the ureteric bud (Mah et al., 2000). Snail binds to the E-cad 
promoter repressing mRNA and protein expression (Nieto, 2002). Depending on 
cell type, snail expression can be repressed by modulators including fibroblast 
growth factor (FGF) releasing inhibitory control of E-cad and inducing 
mesenchymal-to-epiithelial cell transition (Nieto, 2002). Of relevance to our work 
are studies identifying AHR as a transcriptional inducer of snail/slug family 
members (Ikuta and Kawajiri, :2006). In addition to direct regulation via WT1 
(Hosono et al., 2000), it is possible that AHR signaling may regulate E-cad 
expression through snail/slug dependent pathways. While these markers have 
yet to be fully examined in AHR-null mice, the preservation of AHR expression 
and constitutive signaling via expression of AHRd or treatment with antagonist, 
restores their expression. In conclusion, the diverse mechanistic possibilities for 
AHR regulation of renal cell differentiation markers further highlights the 
importance of conservation of AHR signalin~1 in renal cell differentiation and 
development. 
The work presented in this study identified several novel roles for the 
AHR, in addition to its well-established functions as a regulator of XME. 
Evidence compiled from studies using AHR-/- mice, hydrocarbon exposure, and 
nonmammalian AHR homologlues has implicated AHR as an early regulator of 
mammalian development (Falahatpisheh and Ramos, 2003; Falahatpisheh and 
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Ramos, 2007; McMillan and Bradfield, 2007b; Nanez and Ramos, 2007; Puga et 
al., 2005). ExpressiDn of AHR is conserved across vertebrate and invertebrate 
species (Hahn, 2002; Hahn et aI., 2006) with developmental functions ranging 
from limb growth to neuronal development (fDr review (Barouki et al., 2007)). The 
AHR homologue in Drosophila melanogaster Spineless (ss) regulates leg 
structures through both transformation and deletion mechanisms and regulates 
bristle size (Duncan et al., 19918). Loss of AHR 1 in the Calenorhabditis elegans 
ortholog of AHR, results in cell axonal migration deficits resulting in impaired 
neuronal differentiation and function (Duncan et al., 1998; Gin et al., 2006). 
AHR-/- mice exhibit deficits in vascular structures stemming from a failure of the 
ductus venosus to close and result in reduoed liver weight, microvesicular fatty 
metamorphosis, prolonged extramedullary hernatopoeisis, and portal 
hypercellularity (Fernandez-Salguero et al. ,1995; Lahvis et al., 2000; Lahvis et 
al., 2005; Schmidt et aI., 1996). Of direct relevance to renal function are 
experiments in which AHR -/- mice were found to have cardiac hypertrophy and 
elevated mean arterial pressure (Lund et aI., 2003; Lund E:~t aI., 2006). 
Hypertension correlated to inductions in endothelin-1 and angiotensin II, known 
regulators of cardiomyocyte hypertrophy (Gavras and Gavras, 2002; Yamazaki et 
al., 1996). 
In studies of fetal TeDD exposure, a PAH that exerts its biological effects 
solely through AHR disruption, wild type mice exhibited cleft palate, 
hydronephrosis, small kidneys, and tortuous ureters (Peters et al., 1999b). 
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TeOO-induced fetal deficits were shown to be regulated by transcriptional 
activation as mice expressing AHR with a mutated bHLH re9ion (AHRbHLH-/-) 
were protected (Peters et a/., '1999b). This study failed to characterize AHR 
expression which is likely regulating TeDO-induced developmental deficits. 
Thus, it is likely that in wild type mice TeOO activates AHH resulting in 
proteasomal degradation, disruption of AHR si!Jnaling and fE~tal programming. 
However in AHRbHLH-/- mice, TeOO exposure does not result in transcriptional 
activation, a key step in ligand mediated AHR degradation. thus conservinfJ AHR 
protein expression and constitutive signaling. These results support our own 
studies in which siRNA-mediated AHR degradation alters expression of 
differentiation markers and deregulates WT1 activity as WE:!! I as data from AHR-/-
mice (Falahatpisheh et a/., 2007). Further evaluations using alternative mouse 
models of varying AHR genotype such as 02N mice with nonresponsive lifland 
binding AHRd , or AHR-/- null mice lacking AHR protein, will lend further insight to 
this hypothesis. 
The work presented in this study is the first report of a role for AHR in 
alternative splicing. Our model detailing a constitutive function for AHR in VVT1 
regulation is supported by the finding that prevention of AHH loss 
pharmacologically, or by the use of the genetically-resistant 02N strain, 
prevented renal developmental deficits in SaP-treated metanephros, and 
restored normal ratios of WT1 mRNA isoforms. The complexity of AHR functions 
in different transcriptional complexes such as the classicall J\HH-ARNT, NF-
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kappa B, AP-1, and glucocorticoid receptor provides possible mechanisms for 
regulation of WT1 splicing (Figure 4). As mentioned in Chapter 3, the 
glucocorticoid receptor associates with PGC-1, a known rE~'gulator of co-
transcriptional splicing (Knutti et al., 2001). An ongoing focus of the laboratory is 
the possibility of direct binding of AHR to the WT1 promoter. The WT1 promoter 
contains two consensus AHR responsive elements within a re~lulatory region 
known to regulate transcription-coupled splicing events (Cohen et aI., 199/'). 
Wild type mK4 cells and clones expressing stable constructs for siAHR are being 
analyzed by chromatin immunoprecipitation for AHR-WT1 promoter associations. 
AHR may function to alter the splicing machinery directly (Bentley, 2002), or 
indirectly by altering elongation efficiency (Eperon et al., 19B8; Roberts et aI., 
1998). Ohtake et aI., presented a novel role for AHR as an E3 ligase in the 
proteasomal degradation of estrogen (ER) and androgen receptors (AR) through 
associations with proteasomal complexes consisting of DDB 1, ARNT, TBL3 and 
CUL4B, and has E3 ligase activity. We postulate that AHF~ may indirectly 
participate in proteasomal degradation of splicing factors. In fact, ER has been 
shown to associate with spliceosome complexes in the nucleus (Kato et aI., 
2005). This creates a scenario in which AHR through E3 ligase control of ER 
activity inherently regulates assembly and/or processivity of splicing complexes 
necessary for regulation of genes such as WT1 (Figure 5). 
Little is known as to the exact molecular consequences resulting from 
alterations of the four abundant and biologically relevant isoforms of WT1. It is 
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Figure 4. Schematic detailing the complexity of AHR transcriptional 
interactions. Depending upon cell type and stimulus AHR can interact with 
different transcriptional complexes such as the classical AHR-Arnt. NF-k8lppa B, 








Figure 5. AHR may act as an E3 ligase in the proteasomal degradation of 
estrogen and androgen receptor. AHR associates with proteasomal 
complexes consisting of DDB1, Arnt, TBL3 and CUL4B. 
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Figure 5 











well-established that the -KTS mRNA encodes a protein that participates in 
transcriptional activity, and that protein encoding +KTS ml~NA associates with 
splicing factors (Davies et al., 1998; Hastie. 2(01). Mice overexpressing the -
KTS isoform have severely compromised renal development, evidenced by 
increased stromal tissue, decreases in tubular epithelium and glomerular tuft, 
and altered podocyte structure (Hammes et aI., 2001). In both metanephros and 
mK4 cell cultures, BaP-induced shifts in -KTS resulted in downregulation of 
differentiation markers, a finding consistent with the morpbological deficits seen 
in -KTS transgenic mice. However, a potential role of AHR in the regulation of 
WT1 splicing is of importance as human clinical conditions such as Denys--Drash 
syndrome, WAGR, and Frasier syndrome are associated with deregulation of 
normal splice variant ratios (Niaudet and Gubler, 2006). R:estoring WT1 mRNA 
splice variant ratios via AHRd expression di(j not alter renal differentiation 
markers. Transgenic mice expressing solely +17aa WT1 do not exhibit gross 
renal nephropathy (Natoli et aI., 2002), but have deficits in other organ systems 
such as the olfactory system (Wagner et al., 2(05). 
The coordination of cell proliferation, apoptosis, adhesion, migration, 
differentiation, and vasculogenesis is necessary for successful ontogenesis 
(Larsen et aI., 2001). Our data suggests a plausible role for AHR regulation of 
extracellular matrices (ECM) involving cellular interactions between the ureteric 
bud and the metanephric mesenchyme in branching morphogenesis. ECM 
protein expression is tightly regulated via growth factor signaling pathways which 
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in turn are regulated by master switch transcription factors. Cells stemming from 
the ureteric bud must digest ECM proteins to facilitate invasion. Both matrix 
metalloproteases (MMPs) and serine proteases are known to facilitate 
degradation of ECM proteins necessary in renal development. Membrane-type 
matrix 1 (MT-1-MMP), MMP-2, and MMP-9 have been characterized as 
regulators of ECM interaction in the developing kidney (Kanwar et aI., 1999; Ota 
et aI., 1998). Rat models examining the effects of maternal diabetes implicate 
TGF-beta as a possible MMP (Duong Van Huyen et al., 2007). In fact, cDNA 
array studies have revealed that many genes involved in ECM regulation and 
maintenance are targets for the AHR (Andreasen et al., 2006; Hillegass et al., 
2006). In metanephric culture, inhibition of Smad4, a key mediator of TGF-beta, 
in the nephrogenic mesenchyme impairs mesenchymal induction (Oxburgh et al., 
2004). Using mouse fibroblasts of varying AHR genotype, loss of AHR 
expression correlated to increased TGF-beta production and excretion 
suggesting a possible ligand-independent role in TGF-beta regulation (Chang et 
al.,2007). Taken together, these results implicate AHR signaling in the 
regulation of ECM regulatory proteins and pose an alternative mechanism for its 
role in renal development. 
Our model of Matrigel-induced metanephric body formation agrees with 
the known role of (ECM) from both the ureteric bud and the metanephric 
mesenchyme in ureteric branching morpho£lenesis. Matrigel is composed of a 
mixture of mouse tumor derived extracellular matrix proteins including laminin, 
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collagen IV, heparin sulfate proteoglycan and enactin (manufacturer's product 
insert). While the exact makeup of Matrigel remains unknown for proprietary 
reasons, studies have characterized laminin as the most abundant and reactive 
ingredient (Schmeichel and Bissell, 2003). This is of direct interest to our work in 
that lam in ins are key structural proteins in the renal basement membranes 
(Engel, 1993), and known to participate in branching morphogenesis and 
tubulogenesis. Laminin 1, consisting of a-, ~-, and v-subunits, is a critical 
component of epithelial cell polarization chiefly expressed in comma and S-
shaped bodies (Ourbeej et al., 1996; Ekblom, 1993). Of importance to future 
studies, is that exposure to anti-laminin5 blocking antibody inhibits renal 
development of cultured metanephroi by preventing association with a3~1 and 
a6~4-integrin receptors (Zent et al., 2001). Recent studies have implicated 
integrin signaling as effectors for ECM-mediated signaling (Sonnenberg et al., 
1990). In fact exposure to antibodies generated against a1, or a1 ~1Y1-subunits 
inhibits development of cultured metanephroi either through binding of the 
dystroglycan membrane complex or the a6~1-integrin receptor (Sonnenberg et 
al., 1990). Ongoing work is focusing on the identification of the exact 
components necessary for stimulation of metanephric bodies from embryonic 
renal cell lines and the extent of integrin signaling. 
Typically, markers of renal nephropathy such as urinary 
albumin/microprotein, blood urea nitrogen, and creatinine measures generally 
manifest in already severely compromised clinical conditions (Halperin and 
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Kamel, 2000). Similarly, studies examining the embryotoxicity and teratogenicity 
of PAH compounds focused on overt developmental differences (Lummus and 
Henningsen, 1995; MacKenzie and Angevine, 1981 a; Peters et al., 1999a; 
Rodriquez et al., 1999; Wells et al., 1997; Winn and Wells, '1997) Our findings of 
modest changes in glomerular number, urinary albumin, and podocyte number in 
response to PAH exposure highlight the need to reevaluate endpoints for 
developmental deficits and measure subtle effects which are a better estimate of 
human environmental exposure and risk of renal disease. Novel renal 
biomarkers such as RPA 1, GSTYb1, and GSTMu are designed to detect 
nephropathy with more sensitivity than conventional methods (Falkenberg et al., 
1996; Hildebrand et al., 1999; Kilty et aI., 1998). Our laboratory has developed 
expertise in the characterization of modest, significant changes in glomerular cell 
populations that accompanied with traditional pathology can provide a more 
effective, quantitative evaluation of glomerular injury (Nanez et aI., 2005; Nanez 
and Ramos, 2007). 
ThH bioavailability of PAHs from exposures due to incompletH burning of 
organic substances such as gas, oil, wood, tobacco, and charbroiled meat 
present a ready source for potential regulators of development. Average PAH 
exposure can range from 3 to 15 ~g/day depending on dietary intake and are 
doubled with exposure to active or passive tobacco smoke (Menzie et al., 1992a; 
Menzie et al., 1992b; Rebagliato et aI., 1995; Santodonato et al., 1981). 
Classical studies establishing PAHs as known embryotoxic and teratogenic 
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agents used dosages of BaP ranging from 1 0 mg/kg to 250 mg/kg, thus far 
exceedin~1 even that of the highest possible human exposure (Lummus and 
Henningsen, 1995; MacKenzie and Angevine, 1981 a; Rodriquez et al., 1999; 
Wells et a/., 1997; Winn and Wells, 1997). 
To ascertain whether our in vitro model of AHR dependent BaP-induced 
deficits in nephrogenesis correlated to effects obtained from environmentally 
relevant PAH exposure we chose concentrations considerably lower than those 
established for in utero toxicity and teratogenicity (Lummus and Henningsen, 
1995; MacKenzie and Angevine, 1981 a; Rodriquez et al., 1999; Wells et aI., 
1997; Winn and Wells, 1997). When normalized for species-dependent temporal 
difference~s in development, this exposure is representative of human exposures 
of at risk populations (Menzie et aI., 1992a: Menzie et aI., 1992b; Rebagliato et 
aI., 1995). While the classical studies were of great mechanistic importance, 
recent efforts have highlighted the importance of using exposure regimens better 
approximating human models of environmental disease (for reviews see (BeruBe 
et al., 2007; Ng et al., 2006a; Pope, 2007)). Our findings detailing renal deficits 
resulting from in utero BaP exposure are unique in that they chronicle 
nephropathy from early post-birth through adulthood. The use of the D2N mouse 
model allowed us to determine that ligand binding in utero mediates PAH 
induced developmental renal deficits. Our in utero studies not only implicate 
PAH exposure in fetal programming of adult renal diseases and ensuing 
complications, but provide evidence for a direct mechanism, Ongoing work will 
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use genetic mouse models with mutations affecting AHR and WT1 biology to 
further deilineate the mechanisms of PAH-induced renal deficits. 
Our model, in which maternal BaP insul,t results in decreases in podocyte 
number that impair glomerular filtration, is strikingly similar to clinical 
manifestations seen in conditions such as focal segmental glomerulosclerosis 
(FSGS) or diabetic nephropathy (Hara et a/." 2001; Hayden et aI., 2005; Kim et 
a/., 2001 ; Wolf et aI., 2005). Podocytes are terminally differentiated cells that line 
the glomerular basement membrane (GBM) acting as a filter mediated size-
selectivity and must structurally encompass the entire glomerular surface with 
foot processes to maintain proper filtration (Wiggins, 2007). Podocytopenia 
caused by a number of mechanism including toxic, genetic, immune, infectious 
and hemodynamic results in denudation of the GBM that compromise glomerular 
function initiating a cycle of injury and continued podocyte loss leading to 
progressive renal failure (Wiggins, 2007). Glomerulopathies are the most 
common causes of end-stage renal disease worldwide (Hricik et a/., 1998). Of 
interest, are findings from in vivo studies in rats where weekly 10 mg/kg BaP 
exposure of female Sprague-Dawley rats resulted in progressive elevations in 
total urinary protein, protein/creatinine ratios and microalbuminuria (Nanez et a/., 
2005). The nephropathic response involved early reductions in mesangial cell 
numbers coupled to podocyte injury as evidenced by effacement of foot 
processes. Of note was that podocytes, the only renal cell type expressing WT1 
and high AHR protein amounts, in comparison to their glomerular cell types, were 
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affected by BaP exposure. This suggests a scenario, currently being tested, in 
which PAH-induced fetal programming of renal disease may be exacerbated by 
repeated PAH exposures throughout adulthood. Support of this view derives 
from studies showing that BaP exacerbates nephropathy in diabetic rats 
(Valentovic et al., 2006). The impact of in utero BaP exposure on other 
glomerular cell populations such as mesan~Jial and endothelial cells remains to 
be determined. However, we have obtained evidence that BaP compromises 
mesangial and podocyte cell dilfferentiation in adult rats (Nanez et aI., 2005). 
Of relevance to our work is the extensive evidence linking maternal PAH 
exposure to fetal deficits. Some of the strongest evidence of fetal programming 
involves the correlation betweE~n low birth weight (LBW) and compromised renal 
development and initiation of the cycle involving HTN, glomerulosclerosis, 
nephron loss, and progressive renal failure (Celsi et al., 1998; Nwagwu et al., 
2000; Sanders et aI., 2005; Zandi-Nejad et al., 2006). Fetal tobacco syndrome 
characterized by maternal exposure to PAHs in the form of tobacco smoke 
results in reductions in birth weight, height, thoracic circumference (for review 
see (Nieburg et al., 1985). The hypothesis that active smoking morphologically 
alters the placenta compromising fetal capillary function resulting in a reduction 
of oxygen flow to the developing fetus is supported by data in both human and 
rodent models (Bush et al., 2000a; Bush et al., 2000b). Sasaki et al. has 
provided the first in vivo human evidence that AHR, CYP1A1, and GST1 genetic 
polymorph isms influence fetallhealth upon maternal tobacco smoke exposure. 
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Expression of AHR protein with arg/arg at codon 211 significantly lowered birth 
weight and length. Interestingly, variants of enzymes regulated by AHR activity 
(CYP1A1 m1/m2 + m2/m2) or linvolved in PAH elimination (GSTM1 -1-) sensitized 
fetuses to the effects of maternal smoking (Sasaki et al., 2006). This study 
directly links PAH exposure to deficits in AHR signaling in the context of fetal 
programming. 
The increasing bioavailability of exogenous disruptors of AHR signaling 
and the identification of novel endogenous AHR regulators highlights the need for 
a broader understanding of mechanisms by which AHR participates in renal 
development and cellular differentiation. Our results identify AHR-dependent 
glomerular deficiencies as the causative factor of in utero BaP-induced 
deficiencies in renal development. At the mechanistic level, these deficits are 
elicited via disruption of constitutive AHR signaling results in downregulation of 
renal cell differentiation markers, dysregulation of WT1 mRNA splice variants, 
and decreases in direct WT1 transcriptional targets (Figure 6). 
In summary, the work presented in this dissertation defines a novel role for 
the AHR in renal development and in fetal programming of PAH-induced 
environmental disease. Ongoing studies will require further definition of 
molecular interactions between AHR and WT1 and the novel specific roles of 
AHR in the regulation of nephrogenesis. The nature and extent of AHR-
regulated interactions in mediating renal developmental control that set the stage 
179 
Figure 6. Schematic detailing renal cell differentiation.. Renal cells of 
mesenchymal phenotype undergo a series of temporally precise genetic events 
that activate or repress the expression of numerous genetic elements. WT1 is a 
master switch that regulates the key transition from mesenchymal cells to 
epithelial cells. The aryl hydrocarbon receptor (AHR) is an important nuclear 
transcription factor both during embryogenesis and throughout maturity in 
multiple organisms. Evidence is presented that AHR regulates WT1 splice 









for adult renal disease following exposure to environmental ligands of the 
receptor is an important hypothesis that warrants further investigation. 
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